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Maine Center for Disease Control and Prevention (Maine CDC) has published an annual report 
on infectious diseases in Maine for the last 18 years. This report is prepared by the Division of 
Infectious Disease and is intended to provide an overview of notifiable infectious diseases of 
public health importance in Maine.   
 
We could not produce this report without the continued support of our healthcare and public 
health partners throughout the state. We greatly appreciate all of the laboratories, healthcare 
providers, day care centers, school nurses and others who provide disease surveillance 
information. Our partners expend considerable time assisting Maine CDC with infectious 
disease investigations and disease control measures that affect Maine residents. Their active 
and critical role in the infectious disease surveillance cycle informs statewide policies and 
programs that protect our residents from infectious disease through health promotion, disease 
prevention, and early detection, containment, and treatment.   
 
We appreciate and encourage our partners’ vigilance in the effort to protect the people of Maine 
through timely, complete, and accurate notifiable infectious disease reporting. It is through these 
collaborative efforts that we are able to respond to emerging infectious disease threats and 
prevent outbreaks.   
 
We hope you find this report useful as we all work to protect and promote the health of Maine’s 
residents. As always, we welcome your feedback on how we can provide disease information to 
you, our partners.  
 
For more information on what, when, and how to report infectious diseases please see 
Appendix I (Notifiable Conditions List) of this report, visit our website at 
www.mainepublichealth.gov, or call 1-800-821-5821.      
  
 
 
 
 
 
Lori Wolanski, MPH 
Director, Division of Infectious Disease 
Maine Center for Disease Control and 
Prevention 
Stephen Sears, MD, MPH 
State Epidemiologist 
Maine Center for Disease Control and 
Prevention 
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2011 Infectious Disease Surveillance Highlights 
 
• Pertussis cases increased four-fold in 2011 due to community-wide outbreaks in 
Penobscot and Piscataquis counties. Targeted prevention and intervention occurred in 
those areas. 
• Reported cases of shigellosis increased from 8 cases in 2010 to 32 cases in 2011 due to 
a small community wide outbreak in Androscoggin County in which 83% of cases were 
reported in children less than 18 years old. 
• Reported cases of gonorrhea increased in 2011. The highest rates of infection occurred 
in Androscoggin and Cumberland counties.  
• The first case of hantavirus pulmonary syndrome in Maine was identified. 
• Two laboratory confirmed cases of influenza A virus H3N2v associated with exposure to 
pigs were identified in children in Maine. 
• A northeastern regional outbreak of Salmonella typhimurium var copenhagen included 
four Maine residents. A traceback led to a USDA recall. The Maine Health and 
Environmental Testing Laboratory (HETL) isolated the matching strain of Salmonella 
from a patient’s leftover ground beef, confirming the link between human illness and 
ground beef exposure.  
• Over one thousand (1,006) cases of Lyme disease were reported in 2011. Two other 
tickborne diseases, anaplasmosis and babesiosis, also increased in 2011.  
• Chlamydia remained the most commonly reported infectious disease in the state with 
3,094 cases.  Seventy percent of reported infections were in persons 15-24 years of 
age.  
• Twelve cases of confirmed acute hepatitis C were reported to Maine CDC in 2011, 
compared to 2 cases in 2010. The numbers of newly reported cases of chronic hepatitis 
C infections increased from 1,142 in 2010 to 1,184 in 2011. 
• Maine had the lowest rate of tuberculosis in the country, for the second year in a row, at 
0.7 per 100,000 persons. 
• Despite reported cases of giardiasis decreasing in 2011, the rate of giardiasis in Maine 
(12.9 per 100,000 persons) is twice the national rate (6.4 per 100,000 persons). 
• 66 animals tested positive for rabies (32 raccoons, 12 skunks, 11 foxes, 5 bats, 2 feral 
cats, 2 sheep, 1 horse and 1 bobcat). Maine has not had a human case since 1937. 
• Diseases associated with international travel (such as malaria and shigellosis) occurred 
in Maine residents in 2011. As international travel becomes more common and residents 
visit areas with endemic infectious diseases, there is a need to emphasize preventive 
strategies among travelers. 
• Healthcare associated infections, especially Clostridium difficile, are an increasing focus 
of public health. Hospitals are now reporting healthcare associated infections due to 
MRSA and C. difficile. Clusters of C. difficile were reported in three nursing homes in 
2011. 
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Overview of Public Health Surveillance 
The responsibility of government to control and prevent disease dates back hundreds of years.  
Government responsibility was exercised during the epidemics of plague, syphilis, and smallpox 
in the Middle Ages to identify possible sources of disease, isolate infectious cases, and 
quarantine their contacts to prevent further spread of infection.  Illness was monitored, 
regulations were enacted to prevent pollution of streets and public water supplies, and 
instructions issued for appropriate methods of burial and food handling.  
 
Infectious disease surveillance in the United States began soon after the colonies were 
established.  In 1741, Rhode Island passed legislation requiring tavern keepers to report 
contagious disease among their patrons. Two years later, Rhode Island enacted legislation 
requiring the reporting of smallpox, yellow fever, and cholera. National disease surveillance 
began in 1850, when mortality statistics were first published by the federal government based 
on the decennial census.  The legal requirement to collect national morbidity data in the United 
States was initiated in 1878 when Congress authorized the US Public Health Service to collect 
reports of the occurrence of diseases that require quarantine including cholera, plague, 
smallpox, and yellow fever.   
 
In 1885, the Maine State Board of Health was created and consisted of six members appointed 
by the Governor.  Disease reporting for a select few diseases was conducted by the Maine 
Board of Health.  In 1917 the Board was replaced by the Maine Department of Health. 
 
In 2011, 71 infectious diseases were reportable in Maine with 55 considered nationally 
reportable.  The list of reportable infectious diseases in Maine changes periodically, the last 
update was in 2008.  Diseases may be added to the list as new pathogens emerge or when a 
previously recognized pathogen becomes more important.  Some diseases may be removed 
from the list as their incidence or importance declines.  While modern advances in sanitation, 
personal hygiene and immunizations provide greater control and prevention of some diseases, 
other infectious diseases continue to thrive and still other yet-to-be-identified infectious disease 
entities are constantly emerging. Vaccine preventable disease are re-emerging in some parts of 
the world due to decreasing vaccination coverage among children.  
 
The Maine Department of Health and Human Services (DHHS) Center for Disease Control and 
Prevention (Maine CDC) works with healthcare providers and laboratorians to gather infectious 
disease information, analyze it, and provide reports in a timely manner. Surveillance data assist 
us in identifying events that require immediate public health action, such as disease outbreaks 
and emerging diseases; identifying populations at higher risk of infection; monitoring trends in 
the burden of disease; guiding the planning, implementation and evaluation of disease 
prevention and treatment programs; and informing public policy. 
  
The public health "patient" is the community, and information about community health can be 
useful to the clinician providing care to the individual.  Partnership between public health 
professionals, healthcare providers, and clinical laboratories is critical to assure accurate, 
representative and timely information for all.  
 
Disease Reporting in Maine  
Healthcare providers, medical laboratories, healthcare facilities, administrators, health officers, 
veterinarians and others are required to report notifiable diseases to the Maine CDC (Appendix 
I).  Diseases that require specific and immediate public health response or are possible 
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indicators of bioterrorism are to be reported immediately by telephone.  The remainder of 
notifiable conditions are to be reported within 24 or 48 hours of recognition or strong suspicion 
of disease. 
 
Disease reports may be made by electronic laboratory report (ELR), telephone or fax to the 
Maine CDC 24 hours a day, 7 days a week. The reporting numbers are toll free: telephone 1-
800-821-5821 and fax 1-800-293-7534.  An epidemiologist is on call 24 hours a day, 7 days a 
week to respond to infectious disease emergencies.  Disease reports may also be mailed to the 
Division of Infectious Disease, 286 Water Street, 8th Floor, 11 State House Station, Augusta, 
Maine 04333-0011.  Non-confidential reports or requests for consultation can be sent by email 
to disease.reporting@maine.gov.  
 
Infectious disease conditions reportable in Maine, the Rules for the Control of Notifiable 
Conditions and current information regarding infectious disease incidence in Maine are available 
on the Maine CDC website (http://www.maine.gov/dhhs/mecdc/infectious-disease/epi/disease-
reporting/index.shtml).  
 
The Maine Health and Environmental Testing Laboratory (HETL) tests for most reportable 
conditions. Certain organisms are required to be sent to HETL for confirmatory testing and the 
rules for isolate submission can be found on the notifiable conditions list. Information on the 
testing performed at HETL is available at www.mainepublichealth.gov/lab. 
 
Purpose of Report 
The Reportable Infectious Diseases in Maine 2011 Summary provides descriptive epidemiology 
of reportable infectious diseases in Maine and serves as a historical document of public health 
surveillance data. The report allows public health officials to comprehend the burden of 
reportable infectious diseases in Maine.  For example, surveillance data has demonstrated the 
spread of deer ticks and Lyme disease within Maine.   
 
Methods 
The data in this report are based on case definitions developed by the Council of State and 
Territorial Epidemiologists (CSTE) and adopted by federal CDC and the Maine CDC. Case 
definitions may change from year to year. The case definitions used to classify 2011 data are 
available at http://www.cdc.gov/osels/ph_surveillance/nndss/PHS/infdis2011.htm. Cases 
meeting the confirmed or probable case definitions are presented in the annual report.  
 
Tables in the introduction section include all confirmed and probable cases reported to the 
federal CDC for their publications, unless otherwise noted.  Rates are calculated by dividing the 
number of cases by the appropriate population from the yearly U.S. Census estimates and 
multiplying by 100,000. Charts and graphs may not total the final number of cases due to 
missing information on characteristics, such as county of residence, symptom onset date, age 
and gender. 
 
Over time additional information may necessitate review and updates of historical data. The 
most current published report will have the updated historical counts for all diseases. 
 
More detailed information about each disease condition, including educational materials for 
healthcare providers and the general public, is available at www.mainepublichealth.gov. 
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Counts of Selected Reportable Disease by Year, Maine, 2002 – 2011* 
 
Disease 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
Anaplasmosis (HGE) 1 1 1 4 10 9 17 15 17 26 
Babesiosis 2 3 5 11 9 11 11 3 5 9 
Campylobacteriosis 139 146 141 159 137 149 151 171 148 195 
Chlamydia 1801 2040  2120 2253 2304 2543 2594 2443 2586 3094 
Cryptosporidiosis 12 20 22 30 52 56 46 67 93 51 
Dengue Fever 0 0 0 1 4 1 2 3 6 0 
Ehrlichia chaffeensis (HME) 0 0 0 1 4 3 1 1 4 1 
Giardiasis 212 184 155 202 192 197 188 223 223 171 
Gonorrhea 142 231  214 142 137 118 96 143 162 272 
Group A Streptococcal 
Disease (invasive) 
20 28 16 14 19 28 28 21 47 43 
Group B Streptococcal 
Disease, Infant (invasive) 
5 2 1 3 1 1 6 2 8 2 
H. Influenzae (invasive) 2 6 15 12 21 13 21 21 13 26 
Hemolytic uremic syndrome  3 0 2 0 6 1 1 2 1 2 
Hepatitis A, acute 9 16 16 9 8 5 18 1 7 6 
Hepatitis B, acute 14 7 11 14 26 19 15 15 13 8 
Hepatitis B, chronic NA NA NA NA NA 139 142 126 101 105 
Hepatitis C, acute 0 2 0 0 2 1 3 2 2 12 
HIV Infection 39 65  46 59 62 64 46 56 59 54 
Legionellosis 6 2 1 7 11 9 11 10 12 18 
Listeriosis 5 6 8 3 6 5 5 4 1 4 
Lyme disease 218 175 224 245 338 530 909 976 751 1006 
Malaria 6 5 6 5 4 8 1 2 6 6 
Meningococcal disease 9 10 12 2 9 8 6 4 5 5 
MRSA, invasive NR NR NR NR NR NR 47 120 90 121 
Mumps 0 0 0 2 0 24 5 6 2 2 
Pertussis 21 91 195 55 174 83 49 80 53 205 
Rabies, animal 67 82 69 61 127 86 64 56 62 66 
Salmonellosis 147 141 108 163 161 138 159 121 133 134 
Shiga toxin producing E. coli 49 15 18 29 49 41 26 19 21 28 
Shigellosis 10 7 13 15 10 14 20 5 8 32 
Streptococcus pneumoniae, 
invasive 
NA NA NA NA NA NA NA NA 130 136 
Streptococcus pneumoniae 
(drug resistant invasive) 
NR 0 4 8 12 13 18 23 30 32 
Syphilis (early) 3 15  2 3 16 14 20 14 39 20 
Tuberculosis 23 24  20 17 16 19 9 9 8 9 
Varicella (Chickenpox) 792 1012 363 318 238 366 269 235 247 226 
Vibriosis 4 3 4 2 5 0 3 4 5 4 
*Counts may change from year to year. 
NR = not reportable 
NA = not available 
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Rates of Selected Reportable Disease by Year, Maine, 2002 – 2011* 
Disease 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
Anaplasmosis (HGE) 0.1 0.1 0.1 0.4 0.8 0.7 1.3 1.1 1.3 2.0 
Babesiosis 0.2 0.2 0.4 0.8 0.7 0.8 0.8 0.2 0.4 0.7 
Campylobacteriosis 10.7 11.2 10.7 12.1 10.4 11.3 11.5 13.0 11.3 14.7 
Chlamydia 138.9 156.1 161.4 170.9 174.3 192.9 197.0 185.3 197.0 233.0 
Cryptosporidiosis 0.9 1.5 1.7 2.3 3.9 4.3 3.5 5.1 7.1 3.8 
Dengue Fever NR NR NR NR NR NR NR 0.2 0.5 0.0 
Ehrlichia chaffeensis (HME) 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.3 0.1 
Giardiasis 16.4 14.1 11.8 15.3 14.5 15.0 14.3 16.9 17.0 12.9 
Gonorrhea 11.0 17.7 16.3 10.8 10.4 9.0 7.3 10.9 12.3 20.5 
Group A Streptococcal 
Disease (invasive) 
1.5 2.1 1.2 1.1 1.4 2.1 2.1 1.6 3.6 3.2 
H. Influenzae (invasive) 0.2 0.5 1.1 0.9 1.6 1.0 1.6 1.6 1.0 2.0 
Hemolytic uremic syndrome  0.2 0.0 0.2 0.0 0.5 0.1 0.1 0.2 0.1 0.2 
Hepatitis A, acute 0.7 1.2 1.2 0.7 0.6 0.4 1.4 0.1 0.5 0.5 
Hepatitis B, acute 1.1 0.5 0.8 1.1 2.0 1.4 1.1 1.1 1.0 0.6 
Hepatitis B, chronic NA NA NA NA NA 10.6 10.8 9.6 7.7 7.9 
Hepatitis C, acute 0.0 0.2 0.0 0.0 0.2 0.1 0.2 0.2 0.2 0.9 
HIV Infection 3.0 4.2 3.5 4.4 4.3 3.9 3.5 4.3 4.3 4.1 
Legionellosis 0.5 0.2 0.1 0.5 0.8 0.7 0.8 0.8 0.9 1.4 
Listeriosis 0.4 0.5 0.6 0.2 0.5 0.4 0.4 0.3 0.1 0.3 
Lyme disease 16.7 13.4 17.1 18.6 25.6 40.2 69.1 74.0 57.2 75.7 
Malaria 0.5 0.4 0.5 0.4 0.3 0.6 0.1 0.2 0.5 0.5 
Meningococcal disease 0.7 0.1 0.9 0.2 0.7 0.6 0.5 0.3 0.4 0.4 
MRSA, invasive NR NR NR NR NR NR 3.6 9.1 6.9 9.1 
Mumps 0.0 0.0 0.0 0.2 0.0 1.8 0.4 0.5 0.2 0.2 
Pertussis 1.6 7.0 14.8 4.2 13.2 6.3 3.7 6.1 4.0 15.4 
Rabies, animal NA NA NA NA NA NA NA NA NA NA 
Salmonellosis 11.3 10.8 8.2 12.4 12.2 10.5 12.1 9.2 10.1 10.1 
Shiga toxin producing E. coli 3.8 1.2 1.4 2.2 3.7 3.1 2.0 1.4 1.6 2.1 
Shigellosis 0.8 0.5 1.0 1.1 0.8 1.1 1.5 0.4 0.6 2.4 
Streptococcus pneumoniae, 
invasive 
NA NA NA NA NA NA NA NA 9.9 10.2 
Streptococcus pneumoniae 
(drug resistant invasive) 
NR 0.0 0.3 0.6 0.9 
 
1.0 1.4 1.7 2.3 2.4 
Syphilis (early) 0.2 1.2 0.2 0.2 1.2 0.7 1.5 1.1 2.9 1.5 
Tuberculosis 1.8 1.8 1.5 1.3 1.2 1.4 0.7 0.7 0.6 0.7 
Varicella (Chickenpox) 61.1 77.4 27.6 24.1 18.0 27.8 20.4 17.8 18.8 17.0 
Vibriosis 0.3 0.2 0.3 0.2 0.4 0.0 0.2 0.3 0.4 0.3 
*Counts may change from year to year. 
NR = not reportable 
NA = not available
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Reportable Diseases with Historically Small Numbers of Cases, Maine, 2002 - 2011 
 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 10 year total 
Anthrax 0 0 0 0 0 0 0 0 0 0 0 
Botulism, foodborne 2 0 1 0 0 0 0 0 0 0 3 
Brucellosis 0 0 0 0 0 0 0 0 2 0 2 
Creutzfeld-Jacob disease (<55 yo) NR 0 0 0 0 0 0 1 0 0 1 
Cyclosporiasis 0 0 1 0 0 0 0 0 1 0 2 
Diphtheria 0 0 0 0 0 0 0 0 0 0 0 
Encephalitis, Arboviral 0 0 1 0 0 0 0 0 0 0 1 
Hantavirus Pulmonary Syndrome 0 0 0 0 0 0 0 0 0 1 1 
Measles 0 0 0 0 0 0 0 0 0 0 0 
Plague 0 0 0 0 0 0 0 0 0 0 0 
Q fever^ 0 2 0 2 4 7 0 0 0 2 17 
Psittacosis 0 0 1 0 0 0 0 0 0 0 1 
Poliomyelitis 0 0 0 0 0 0 0 0 0 0 0 
Rubella 0 0 0 0 0 0 0 0 0 0 0 
Rocky Mountain Spotted Fever^ NR NR NR NR NR NR 1 5 2 1 9 
Severe Acute Respiratory 
Syndrome (SARS) NR 0 0 0 0 0 0 0 0 0 0 
Smallpox 0 0 0 0 0 0 0 0 0 0 0 
Tetanus 1 0 0 0 0 0 0 0 0 0 1 
Streptococcal Toxic Shock 
Syndrome 1 1 1 0 0 1 0 0 21 12 37 
Toxoplasmosis 0 0 1 0 0 0 0 0 0 0 1 
Trichinosis 0 0 0 0 0 0 0 0 1 1 2 
Tularemia 0 0 0 0 0 0 0 0 0 0 0 
Typhoid Fever 0 0 0 0 1 0 0 0 2 0 3 
Venezuelan Equine Encephalitis NR 0 0 0 0 0 0 0 0 0 0 
West Nile Virus  NR 0 0 0 0 0 0 0 0 0 0 
Yellow Fever NR NR 0 0 0 0 0 0 0 0 0 
NR=Not reportable, ^Reported cases were probable only in 2011 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2011 
 Anaplasmosis Babesiosis Campylobacteriosis Cryptosporidiosis Ehrlichia 
chaffeensis 
Giardiasis 
County No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate 
Androscoggin 0 0.0 0 0.0 14 13.0 0 0.0 0 0.0 15 14.0 
Aroostook 0 0.0 0 0.0 6 8.4 4 5.6 0 0.0 2 2.8 
Cumberland 9 3.2 1 0.4 44 15.6 4 1.4 0 0.0 60 21.2 
Franklin 0 0.0 0 0.0 4 8.0 0 0.0 0 0.0 3 9.8 
Hancock 1 1.8 0 0.0 4 7.3 2 3.7 0 0.0 4 7.3 
Kennebec 2 1.6 0 0.0 23 18.9 4 3.3 0 0.0 14 11.5 
Knox 1 2.5 1 2.5 1 2.5 2 5.0 0 0.0 6 15.1 
Lincoln 7 20.5 1 2.9 4 11.7 4 11.7 0 0.0 7 20.5 
Oxford 0 0.0 0 0.0 9 15.6 0 0.0 0 0.0 8 13.9 
Penobscot 0 0.0 0 0.0 25 16.3 13 8.5 0 0.0 11 7.2 
Piscataquis 0 0.0 0 0.0 2 11.5 1 5.7 0 0.0 1 5.7 
Sagadahoc 3 8.5 0 0.0 6 17.0 3 8.5 0 0.0 9 25.6 
Somerset 0 0.0 0 0.0 15 28.8 4 7.7 1 1.9 15 28.8 
Waldo 0 0.0 0 0.0 3 7.7 6 15.5 0 0.0 5 12.9 
Washington 0 0.0 0 0.0 3 9.2 0 0.0 0 0.0 0 0.0 
York 3 1.5 6 3.0 32 16.1 4 2.0 0 0.0 11 5.5 
Maine Total 26 2.0 9 0.7 195 14.7 51 3.8 1 0.1 171 12.9 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2011 
 Haemophilus 
influenzae, invasive 
Hemolytic uremic 
syndrome 
Hepatitis A Hepatitis B, acute Hepatitis B, 
chronic 
Legionellosis 
County No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate 
Androscoggin 4 3.7 1 0.9 0 0.0 1 0.9 7 6.5 2 1.9 
Aroostook 0 0.0 0 0.0 0 0.0 1 1.4 3 4.2 0 0.0 
Cumberland 5 1.8 0 0.0 1 0.4 0 0.0 54 19.1 6 2.1 
Franklin 0 0.0 0 0.0 0 0.0 0 0.0 1 3.3 1 3.3 
Hancock 1 1.8 0 0.0 0 0.0 1 1.8 2 3.7 0 0.0 
Kennebec 0 0.0 1 0.8 0 0.0 1 0.8 10 8.2 1 0.8 
Knox 0 0.0 0 0.0 1 2.5 0 0.0 3 7.6 0 0.0 
Lincoln 3 8.8 0 0.0 4 11.7 0 0.0 2 5.8 1 2.9 
Oxford 1 1.7 0 0.0 0 0.0 1 1.7 1 1.7 0 0.0 
Penobscot 5 3.3 0 0.0 0 0.0 1 0.7 5 3.3 1 0.7 
Piscataquis 1 5.7 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 
Sagadahoc 0 0.0 0 0.0 0 0.0 1 2.8 1 2.8 0 0.0 
Somerset 2 3.8 0 0.0 0 0.0 1 1.9 2 3.8 3 5.8 
Waldo 1 2.6 0 0.0 0 0.0 0 0.0 3 7.7 0 0.0 
Washington 0 0.0 0 0.0 0 0.0 0 0.0 2 6.1 0 0.0 
York 3 1.5 0 0.0 0 0.0 0 0.0 9 4.5 3 1.5 
Maine Total 26 2.0 2 0.2 6 0.5 8 0.6 105 7.9 18 1.4 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2011 
 Listeriosis Lyme Disease Malaria Meningococcal 
invasive disease 
MRSA, invasive Mumps 
County No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate 
Androscoggin 0 0.0 58 54.0 0 0.0 0 0.0 5 4.7 0 0.0 
Aroostook 0 0.0 3 4.2 0 0.0 0 0.0 4 5.6 0 0.0 
Cumberland 0 0.0 275 97.4 2 0.7 1 0.4 30 10.6 2 0.7 
Franklin 0 0.0 6 19.5 0 0.0 0 0.0 0 0.0 0 0.0 
Hancock 0 0.0 43 78.8 0 0.0 0 0.0 7 12.8 0 0.0 
Kennebec 1 0.8 129 105.8 1 0.8 1 0.8 11 9.0 0 0.0 
Knox 0 0.0 103 259.4 0 0.0 0 0.0 6 15.1 0 0.0 
Lincoln 0 0.0 53 154.9 0 0.0 0 0.0 4 11.7 0 0.0 
Oxford 0 0.0 28 48.5 0 0.0 0 0.0 5 8.7 0 0.0 
Penobscot 0 0.0 11 7.2 0 0.0 1 0.7 8 5.2 0 0.0 
Piscataquis 0 0.0 6 34.4 0 0.0 0 0.0 3 17.2 0 0.0 
Sagadahoc 0 0.0 47 133.5 0 0.0 0 0.0 4 11.4 0 0.0 
Somerset 1 1.9 9 17.3 0 0.0 0 0.0 10 19.2 0 0.0 
Waldo 1 2.6 25 64.5 0 0.0 1 2.6 5 12.9 0 0.0 
Washington 0 0.0 12 36.8 1 3.1 0 0.0 2 6.1 0 0.0 
York 1 0.5 198 100.4 2 1.0 1 0.5 17 8.6 0 0.0 
Maine Total 4 0.3 1006 75.7 6 0.5 5 0.4 121 9.1 2 0.2 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2011 
 Pertussis Rabies, animal Salmonellosis Shiga toxin 
producing E. coli 
Shigellosis 
County No. Rate No. Rate No. Rate No. Rate No. No. 
Androscoggin 1 0.9 4  17 15.8 1 0.9 24 22.3 
Aroostook 0 0.0 0  6 8.4 1 1.4 0 0.0 
Cumberland 12 4.2 20  28 9.9 5 1.8 6 2.1 
Franklin 1 3.3 4  5 16.3 2 6.5 0 0.0 
Hancock 10 18.3 0  1 1.8 0 0.0 1 1.8 
Kennebec 6 4.9 5  11 9.0 2 1.6 0 0.0 
Knox 1 2.5 4  9 22.7 1 2.5 0 0.0 
Lincoln 1 2.9 3  4 11.7 0 0.0 0 0.0 
Oxford 3 5.2 8  6 10.4 3 5.2 0 0.0 
Penobscot 137 89.1 3  5 3.3 3 2.0 0 0.0 
Piscataquis 18 103.3 0  1 5.7 1 5.7 0 0.0 
Sagadahoc 2 5.7 3  1 2.8 3 8.5 0 0.0 
Somerset 2 3.8 4  3 5.8 2 3.8 0 0.0 
Waldo 5 12.9 4  10 25.8 1 2.6 0 0.0 
Washington 1 3.1 0  1 3.1 0 0.0 0 0.0 
York 5 2.5 4  26 13.1 3 1.5 1 0.5 
Maine Total 205 15.4 66  134 10.1 28 2.1 32 2.4 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2011 
 Streptococcus, 
invasive Group A 
Streptococcus 
pneumoniae, invasive 
Tuberculosis Varicella 
(Chickenpox) 
Vibriosis 
County No. Rate No. Rate No. Rate No. Rate No. Rate 
Androscoggin 5 4.7 16 14.9 2 1.9 16 14.9 0 0.0 
Aroostook 3 4.2 9 12.6 0 0.0 3 4.2 0 0.0 
Cumberland 10 3.5 34 12.0 2 0.7 51 18.1 0 0.0 
Franklin 0 0.0 1 3.3 1 3.3 4 13.0 0 0.0 
Hancock 0 0.0 0 0.0 0 0.0 36 66.0 0 0.0 
Kennebec 8 6.6 23 18.9 2 1.6 10 8.2 0 0.0 
Knox 0 0.0 2 5.0 0 0.0 9 22.7 1 2.5 
Lincoln 1 2.9 5 14.6 0 0.0 3 8.8 2 5.8 
Oxford 5 8.7 5 8.7 0 0.0 3 5.2 0 0.0 
Penobscot 5 3.3 10 6.5 0 0.0 30 19.5 0 0.0 
Piscataquis 0 0.0 0 0.0 0 0.0 6 34.4 0 0.0 
Sagadahoc 0 0.0 5 14.2 0 0.0 3 8.5 0 0.0 
Somerset 3 5.8 6 11.5 0 0.0 9 17.3 0 0.0 
Waldo 0 0.0 3 7.7 1 2.6 12 31.0 0 0.0 
Washington 0 0.0 2 6.1 0 0.0 5 15.3 0 0.0 
York 3 1.5 15 7.6 1 0.5 26 13.1 1 0.5 
Maine Total 43 3.2 136 10.2 9 0.7 226 17.0 4 0.3 
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Reportable HIV/STDs, Number of Cases and Rate per 100,000 Persons by County, Maine, 2011 
 Chlamydia Gonorrhea Syphilis, Primary and 
Secondary* 
HIV 
County No. Rate No. Rate No. Rate No. Rate 
Androscoggin 366 340.8 92 85.7 2 1.9 2 1.9 
Aroostook 119 166.5 6 8.4 0 0.0 4 5.6 
Cumberland 748 264.9 107 37.9 6 2.1 26 9.2 
Franklin 70 227.7 0 0.0 0 0.0 2 6.5 
Hancock 95 174.1 1 1.8 2 3.7 1 1.8 
Kennebec 351 287.9 5 4.1 1 0.8 3 2.5 
Knox 74 186.4 3 7.6 1 2.5 1 2.5 
Lincoln 45 131.5 2 5.8 0 0.0 0 0.0 
Oxford 93 161.2 6 10.4 0 0.0 0 0.0 
Penobscot 288 187.3 21 13.7 1 0.7 3 2.0 
Piscataquis 24 137.8 0 0.0 0 0.0 0 0.0 
Sagadahoc 112 318.1 4 11.4 1 2.8 1 2.8 
Somerset 106 203.7 1 1.9 0 0.0 2 3.8 
Waldo 49 126.5 1 2.6 0 0.0 0 0.0 
Washington 83 254.3 8 24.5 0 0.0 0 0.0 
York 471 237.6 15 7.6 6 3.0 9 4.5 
Maine Total 3094 233.0 272 20.5 20 1.5 54 4.1 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by District, Maine, 2011 
Condition Aroostook Central Cumberland Downeast Mid Coast 
No. Rate No. Rate No. Rate No. Rate No. Rate 
Anaplasmosis 0 0.0 2 1.1 9 3.2 1 1.1 11 7.4 
Babesiosis 0 0.0 0 0.0 1 0.4 0 0.0 2 1.4 
Campylobacteriosis 6 8.4 38 21.8 44 15.6 7 8.0 14 9.5 
Chlamydia 119 166.5 457 262.7 748 264.9 178 204.1 280 189.3 
Cryptosporidosis 4 5.6 8 4.6 4 1.4 2 2.3 15 10.1 
Ehrlichia chaffeensis 0 0.0 1 0.6 0 0.0 0 0.0 0 0.0 
Giardiasis 2 2.8 29 16.7 60 21.2 4 4.6 27 18.3 
Gonorrhea 6 8.3 6 3.4 107 38.0 9 10.3 10 6.7 
Haemophilus influenzae, invasive 0 0.0 2 1.1 5 1.8 1 1.1 4 2.7 
Hemolytic uremic syndrome 0 0.0 1 0.6 0 0.0 0 0.0 0 0.0 
HIV 4 5.6 5 2.9 26 9.2 1 1.1 2 1.3 
Hepatitis A 0 0.0 0 0.0 1 0.4 0 0.0 5 3.4 
Hepatitis B, acute 1 1.4 2 1.1 0 0.0 1 1.1 1 0.7 
Hepatitis B, chronic 3 4.2 12 6.9 54 19.2 4 4.6 9 6.1 
Legionellosis 0 0.0 4 2.3 6 2.1 0 0.0 1 0.7 
Listeriosis 0 0.0 2 1.1 0 0.0 0 0.0 1 0.7 
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 Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by District, Maine, 2011 
Condition Penquis Western York State 
No. Rate No. Rate No. Rate No. Rate 
Anaplasmosis 0 0.0 0 0.0 3 1.5 26 2.0 
Babesiosis 0 0.0 0 0.0 6 3.0 9 0.7 
Campylobacteriosis 27 15.8 27 13.8 32 7.6 195 14.7 
Chlamydia 312 182.2 529 270.1 471 238.9 3094 233.0 
Cryptosporidosis 14 8.2 0 0.0 4 2.0 51 3.8 
Ehrlichia chaffeensis 0 0.0 0 0.0 0 0.0 1 0.1 
Giardiasis 12 7.0 26 13.3 11 5.5 171 12.9 
Gonorrhea 21 12.2 98 49.9 15 7.6 272 20.5 
Haemophilus influenzae, invasvie 6 3.5 5 2.6 3 1.5 26 2.0 
Hemolytic uremic syndrome 0 0.0 1 0.5 0 0.0 2 0.2 
HIV 3 1.7 4 2.0 9 4.5 54 4.1 
Hepatitis A 0 0.0 0 0.0 0 0.0 6 0.5 
Hepatitis B, acute 1 0.6 2 1.0 0 0.0 8 0.6 
Hepatitis B, chronic 5 2.9 9 4.6 9 4.6 105 7.9 
Legionellosis 1 0.6 3 1.5 3 1.5 18 1.4 
Listeriosis 0 0.0 0 0.0 1 0.5 4 0.3 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by District, Maine, 2011 
Condition Aroostook Central Cumberland Downeast Mid Coast 
No. Rate No. Rate No. Rate No. Rate No. Rate 
Lyme Disease 3 4.2 138 79.3 275 97.4 55 63.1 228 154.2 
Meningococcal invasive disease 0 0.0 1 0.6 1 0.4 0 0.0 1 0.7 
MRSA, invasive 4 5.6 21 12.1 30 10.6 9 10.3 19 12.8 
Mumps 0 0.0 0 0.0 2 0.7 0 0.0 0 0.0 
Pertussis 0 0.0 8 4.6 12 4.2 11 12.6 9 6.1 
Rabies, animal 0  9  20  0  14  
Salmonellosis 6 8.3 14 8.0 28 9.9 2 2.3 24 16.2 
Shiga toxin producing E. coli 1 1.4 4 2.3 5 1.8 0 0.0 5 3.4 
Shigellosis 0 0.0 0 0.0 6 2.1 1 1.1 0 0.0 
Streptococcus, invasive Group A 3 4.2 11 6.3 10 3.5 0 0.0 1 0.7 
Streptococcus pneumoniae, 
invasive  9 12.6 29 16.7 34 12.0 2 2.3 15 10.1 
Syphilis 0 0.0 1 0.6 6 2.1 2 2.3 2 1.4 
Tuberculosis 0 0.0 2 1.1 2 0.7 0 0.0 1 0.7 
Varicella (chickenpox) 3 4.2 19 10.9 51 18.1 41 47.0 27 18.3 
Vibriosis 0 0.0 0 0.0 0 0.0 0 0.0 3 2.0 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by District, Maine, 2011 
Condition Penquis Western York State 
No. Rate No. Rate No. Rate No. Rate 
Lyme Disease 17 9.9 92 47.0 198 99.9 1006 75.7 
Meningococcal invasive disease 1 0.6 0 0.0 1 0.5 5 0.4 
MRSA, invasive 11 6.4 10 5.1 17 8.6 121 9.1 
Mumps 0 0.0 0 0.0 0 0.0 2 0.2 
Pertussis 155 90.5 5 2.6 5 2.5 205 15.4 
Rabies, animal 3  16  4  66  
Salmonellosis 6 3.5 28 14.3 26 13.1 134 10.1 
Shiga toxin producing E. coli 4 2.3 6 3.1 3 1.5 28 2.1 
Shigellosis 0 0.0 24 12.3 1 0.5 32 2.4 
Streptococcus, invasive Group A 5 2.9 10 5.1 3 1.5 43 3.2 
Streptococcus pneumoniae, 
invasive  10 5.8 22 11.2 15 7.6 136 10.2 
Syphilis  1 0.6 2 1.0 6 3.0 20 1.5 
Tuberculosis 0 0.0 3 1.5 1 0.5 9 0.7 
Varicella 36 21.0 23 11.7 26 13.1 226 17.0 
Vibriosis 0 0.0 0 0.0 1 0.5 4 0.3 
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Anaplasmosis 
2011 Case Total 26 
Maine Rate 2.0 per 100,000 
U.S. rate (2010) 0.6 per 100,000 
Anaplasmosis Incidence, Maine and US, 
2007-2011
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Anaplasmosis is a disease caused by the 
b a c t e r i u m  A n a p l a s m a 
phagocytophilium.   Anaplasmosis was 
p r e v i o u s l y  k n o w n  a s  h u m a n 
granulocytic ehrlichiosis (HGE) or 
human granulocytic anaplasmosis 
(HGA).   
 
Signs and symptoms of anaplasmosis 
include:  fever, headache, malaise, and 
body aches.  Anaplasmosis is 
transmitted to a person by the bite of an 
infected deer tick (Ixodes scapularis), 
one of the most common ticks in Maine. 
 
 Case total of 26 represents an  
increase from 17 cases in 2010 
 The 2006-2010 median number of 
cases per year was 16 
 Median age was 66 years 
 Age range was 30 to 92 years 
 Cases were 31% female and 69% 
male 
 Greatest number of cases occurred 
during the summer and winter months 
 
The best way to prevent infection is to 
take measures to protect against tick 
bites.  Checking for ticks after visiting a 
tick infested area is an important way to 
reduce the risk of contracting 
anaplasmosis.  Using EPA approved 
repellents such as DEET on skin or 
permethrin on clothing is a good way to 
protect against tick bites. Always follow 
the instructions on the label when 
applying repellent products. If an 
engorged tick is found, it should be 
safely removed and saved for 
identification. Monitor for signs and 
symptoms for 30 days after the tick bite. 
 
For more information about submitting 
a tick for identification only (not 
testing) visit www.mmcri.org/lyme.    
*onset date missing for one case 
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Babesiosis 
2011 Case Total 9 
Maine Rate 0.7 per 100,000 
U.S. rate (2010) Not reportable 
Babesiosis Incidence, Maine, 2007-2011
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Babesiosis is caused by a parasite that 
may be carried by ticks.  Many 
individuals that get the disease do not 
have symptoms.  Serious symptoms can 
occur, especially in persons who are 
immunosuppressed, those without a 
spleen, or people who are co-infected 
with Lyme disease.  Babesiosis may 
also occur after a blood transfusion 
from an infected donor. 
 
Common symptoms include extreme 
fatigue, aches, fever, chills, sweating, 
dark urine, and possibly anemia.   
 
 Case total of 9 represents an increase 
from 5 cases in 2010 
 The 2006-2010 median number of 
cases was 9 
 Median age was 66 years 
 Age range was 23 to 83 years 
 Cases were 67% female and 33% 
male 
 Greatest number of cases occurred 
during the summer months 
 One death was reported 
 
The best way to prevent infection is to 
take measures to protect against tick 
bites.  Checking for ticks after visiting a 
tick infested area is an important way to 
reduce the risk of contracting 
babesiosis.  Using EPA approved 
repellents such as DEET on skin or 
permethrin on clothing is a good way to 
protect against tick bites. Always follow 
the instructions on the label when 
applying repellent products. If an 
engorged tick is found, it should be 
safely removed and saved for 
identification. Monitor for signs and 
symptoms for 30 days after the tick bite. 
 
For more information about submitting 
a tick for identification only (not 
testing) visit www.mmcri.org/lyme.    
*onset date missing for two cases 
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Campylobacteriosis 
2011 Case Total 195 
Maine Rate 14.7 per 100,000 
U.S. rate (2010) Not reportable 
Campylobacteriosis Incidence, Maine, 
2007-2011
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Campylobacteriosis is one of the most 
common infectious diseases causing 
diarrhea in the United States.  
Symptoms include diarrhea, cramping, 
abdominal pain and fever. Most people 
recover within 5 to 10 days.  
 
Campylobacteriosis is associated with 
handling raw poultry or eating 
undercooked poultry meat, consuming 
unpasteurized milk and other dairy 
products and from exposure to 
contaminated foods. Raw foods, such as 
vege t ab l e s  o r  s a l ad ,  c an  b e 
contaminated if the same cutting board 
or utensils are used for both raw foods 
and raw poultry items and not cleaned 
between preparations.  
 
• Case total of 195 represents an 
increase from 148 cases in 2010 
• The 2006-2010 median number of 
cases was 149   
• Median age was 48 years 
• Age range was 2 months to 89 years 
• Cases were 46% female and 54% 
male 
• Highest rates in Somerset, Kennebec, 
Penobscot and York counties 
• Greatest number of cases occurred 
during the summer months  
 
To prevent illness, individuals should 
cook poultry and other meats properly, 
avoid consuming untreated water, raw 
mi lk and  milk products ,  and 
unpasteurized juice. 
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Chlamydia 
2011 Case Total 3,094 
Maine Rate 233.0 per 100,000 
U.S. rate (2010) 426.0 per 100,000 
Chlamydia Incidence, Maine and US, 2007-2011
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Chlamydia is a sexually transmitted 
disease (STD) caused by the bacterium 
Chlamydia trachomatis.  Chlamydia is 
known as a “silent” disease, as three 
quarters (75%) of women and half 
(50%) of men infected with chlamydia 
will have no symptoms.  Common 
symptoms for women include vaginal 
discharge or a burning sensation with 
urination and for men include penile 
discharge and a burning on urination.  
 
If chlamydia is not treated, the infection  
may cause serious damage to the 
reproduct ive system, including 
infertility.  Chlamydia can be passed to 
a child during birth.  People with 
chlamydia can more easily contract HIV 
from someone else  or transmit HIV to 
others if they are infected with both.    
   
 Chlamydia is the most frequently 
reported STD in Maine 
 In 2011 three women were 
diagnosed for every one man 
 70% of infections were in persons 
15-24 years old 
 Cases were 69% female and 31% 
male 
 
Chlamydia can be prevented by the use 
of latex or polyurethane condoms and 
dental dams during anal, vaginal, and 
oral sex. Efforts to prevent the spread of 
chlamydia include prioritized follow up 
activities for new diagnoses  and the 
Infertility Prevention Project, a federal 
CDC sponsored initiative, that targets 
testing and treatment for females 15-24 
years old and their partners.  Currently 
free testing for females 15-24 is 
available at Family Planning and 
Planned Parenthood sites, and at the 
three STD clinics (Bangor, Portland and 
Lewiston).  
 
*unknown age for 10 cases. 
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Cryptosporidiosis 
2011 Case Total 51 
Maine Rate 3.8 per 100,000 
U.S. rate (2010) 2.9 per 100,000 
Cryptosporidiosis Incidence, Maine and US, 
2007-2011
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Cryptosporidiosis is an infection most 
frequently associated with contaminated 
water or contact with infected animals. 
The disease is caused by a parasite that 
lives in the intestines of animals and 
infected humans.  Feces containing the 
parasite may contaminate the ground or 
water sources.  The parasite may live 
for long periods of time in the 
environment due to a protective outer 
covering. It is resistant to many chlorine
-based disinfectants, increasing the risk 
of transmission in swimming pools and 
waterparks. 
 
Symptoms include diarrhea, abdominal 
cramping, malaise and vomiting. 
 
• Case total of 51 represents a decrease 
from 93 cases in 2010 
• The 2006-2010 median number of 
cases per year was 56 
• Median age was 39 years 
• Age range was 2 years to 87 years 
• Cases were 57% female and 43% 
male 
• Highest incidence was in Waldo, 
Lincoln and Sagadahoc counties 
 
Preventive measures include consuming 
pasteurized milk and dairy products, 
practicing good hand hygiene around 
farm animals and discouraging  persons 
of all ages from swimming when they 
have diarrheal illness. 
*onset date missing for one case 
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Ehrlichiosis 
2011 Case Total 1 
Maine Rate 0.1 per 100,000 
U.S. rate (2010) 0.2 per 100,000 
Ehrlichiosis Incidence, Maine and US, 
2007-2011
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Ehrlichiosis is a disease caused by the 
bacterium Ehrlichia chaffeensis which 
infects white blood cells (monocytes).  
Ehrlichia chaffeensis was previously 
known as human monocytic ehrlichiosis 
(HME).   
 
Signs and symptoms of ehrlichiosis 
include:  fever, headache, nausea, and 
body aches.  Ehrlichiosis is transmitted 
to a person through the bite of an 
infected lone star tick (Amblyomma 
americanum), an uncommon tick in 
Maine.    
 
 Case total of 1 confirmed case 
represents a decrease from 4 probable 
cases in 2010 
 The 2006-2010 median number of 
cases per year was 3 
 
The best way to prevent infection is to 
take measures to protect against tick 
bites.  Checking for ticks after visiting a 
tick infested area is an important way to 
reduce the risk of contracting 
ehrlichiosis.  Using EPA approved 
repellents such as DEET on skin or 
permethrin on clothing is a good way to 
protect against tick bites. Always follow 
the instructions on the label when 
applying repellent products. If an 
engorged tick is found, it should be 
safely removed and saved for 
identification. Monitor for signs and 
symptoms for 30 days after the tick bite. 
 
For more information about submitting 
a tick for identification only (not 
testing) visit www.mmcri.org/lyme.    
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Giardiasis 
2011 Case Total 171 
Maine Rate 12.9 per 100,000 
U.S. rate (2010) 6.4 per 100,000 
Giardiasis Incidence, Maine and US, 2007-2011
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Giardiasis is sometimes known as 
“beaver fever” because beavers (as well 
as dogs, cats, horses and cows) are 
major reservoirs for the parasite 
(Giardia lamblia) that causes the 
infection. The parasite lives in the 
intestines of infected humans and 
animals and when expelled through the 
feces can contaminate water and  
surfaces. Animal feces can infect ponds 
and streams and if hikers or others drink 
water in the wild without proper 
treatment they may become infected. 
Young children in child care or pool 
settings who are prone to sucking on 
toys or swallowing water are also at 
higher risk. 
 
• Case total of 171 represents a 
decrease from 223 cases in 2010  
• The 2006-2010 median number of 
cases per year was 197  
• Median age was 40 years 
• Age range was 1 year to 88 years 
• Cases were 45% female and 55% 
male 
• Highest incidence was in Somerset, 
Sagadahoc, Cumberland and Lincoln 
counties 
• Greatest number of cases occurred 
during the late summer  and fall 
months 
 
Individuals can prevent this illness by 
not drinking from untreated water 
sources, such as streams and lakes.  
Increased attention to proper sanitation 
and hygiene in public water recreational 
facilities can help to reduce the 
transmission of Giardia. 
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Gonorrhea 
2011 Case Total 272 
Maine Rate 20.5 per 100,000 
U.S. rate (2010) 100.8 per 100,000 
Gonorrhea Incidence, Maine and US, 2007-2011
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Gonorrhea is a sexually transmitted 
disease (STD) caused by the bacterium 
Neisseria gonorrhoeae that grows and 
multiplies in warm, moist areas 
(mucous membranes).  Gonorrhea can 
be spread through contact with the 
vagina, penis, mouth or anus.  
Gonorrhea can also spread from a 
mother to her baby during childbirth.  
Gonorrhea does not always cause 
symptoms.  Men may feel a burning 
sensation while urinating, or have  
discharge from their penis.  Women 
might feel pain with urination, or notice 
discharge from their vagina.   
 
Gonorrhea is dangerous if untreated.  In 
women, gonorrhea is a common cause 
of pelvic inflammatory disease, which 
can lead to chronic pain and infertility.  
In  men,  gonorrhea can cause 
epididymitis, causing painful testicles 
and  infertility.  People infected with 
HIV are more likely to contract 
gonorrhea and to transmit HIV if they 
are also infected with gonorrhea.     
 
• Case total of 272 represents an 
increase from 162 cases in 2010  
• Highest incidence was in the 15-24 
year age group, with a total of 38% of 
cases   
• Cases were 45% female and 55% 
male 
 
Gonorrhea can be prevented by using 
latex or polyurethane condoms and 
dental dams during anal, vaginal, and 
oral sex. Prevention efforts include 
treatment verification and case 
investigation activities, such as partner 
follow-up for all new  infections. State 
sponsored testing through the Infertility 
Prevention Project uses a combination 
gonorrhea and chlamydia test targeting 
females 15-24 years old. 
Gonorrhea by Month, Maine, 2011
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Group A Streptococcal 
Disease 
2011 Case Total 43 
Maine Rate 3.2 per 100,000 
U.S. rate (2010) Not reportable 
Invasive GAS Incidence, Maine and US 2007-
2011
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Group A Streptococcus (GAS) is a 
bacterium often found in the throat and on 
the skin that can cause either no 
symptoms (colonization) or mild 
symptoms such as pharyngitis (strep 
throat), cellulitis (soft tissue infection) or 
impetigo (skin dermatitis).  When the 
bacteria enters deeper tissues and the 
blood stream, GAS can cause severe or 
life-threatening conditions. 
 
Necrotizing fasciitis, a condition that 
progressively destroys skin, fat and 
muscles, can be caused by GAS.  Another 
example of an invasive GAS disease is 
Streptococcal Toxic Shock Syndrome 
(STSS), a rapid drop in blood pressure 
that causes organ failure. 
 
 Case total of 43 represents a decrease 
from 47 cases in 2010 
 The 2006-2010 median number of 
cases per year was 28  
 Median age was 56 years 
 Age range was 8 months to 96 years 
 Cases were 42% female and 58% male 
 12 (28%) cases were also diagnosed 
with STSS; 4 of these cases died 
 
Control and prevention strategies may 
include targeted chemoprophylaxis for 
high risk household contacts of confirmed 
cases, such as those who are 65 and older 
or those who have other specified risk 
factors (HIV infection, diabetes, 
malignancy, injecting drug use, or cardiac 
diseases). 
*onset date missing for two cases 
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Haemophilus influenzae 
2011 Case Total 26 
Maine Rate 2.0 per 100,000 
U.S. rate (2010) 1.0 per 100,000 
Haemophilus influenzae  Incidence, Maine and 
US, 2007-2011
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Haemophilus influenzae disease is 
caused by the Haemophilus influenzae 
bacterium.  A specific type called H. 
influenzae serotype B (Hib), was once 
the most common cause of bacterial 
meningitis in children.  Due to 
widespread use of Hib vaccine, few 
cases in children less than 5 years old 
are reported each year.   
 
The bacteria are spread from person to 
person, through airborne droplets, when 
an infected person coughs or sneezes.  
H. influenzae can cause severe illnesses 
such as meningitis, bacteremia, 
pneumonia and septic arthritis. 
 
• Case total of 26 represents an 
increase from 13 cases in 2010 
• The 2006-2010 median number of 
cases per year was 21  
• Median age was 66 years 
• Age range was 2 years to 97 years 
• Cases were 50% female and 50% 
male 
• No cases of Hib (type b) in children 
aged < 15 years were reported 
 
Haemophilus influenzae serotype b 
(Hib) may be prevented in children 
through vaccination.  Vaccination is 
recommended for all children at ages 2, 
4 and 6 months or at 2 and 4 months 
depending on the type of vaccine 
available.  An additional booster dose is 
given at 12-15 months of age with either 
type of vaccine. 
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Hepatitis A 
2011 Case Total 6 
Maine Rate 0.5 per 100,000 
U.S. rate (2010) 0.5 per 100,000 
Hepatitis A Incidence, Maine and US, 2007-2011
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Hepatitis A is a liver disease caused by 
hepatitis A virus (HAV). The virus is 
spread from person to person by fecal-
oral transmission that involves putting 
something in the mouth (such as food or 
water) that has been contaminated by a 
person infected with hepatitis A.  Poor 
handwashing by persons with infection 
increases the risk of transmission. The 
virus spreads more easily in areas where 
sanitary conditions and personal 
hygiene practices are poor.  Most 
infections result from exposure during 
international travel, or contact with a 
household member or a sexual partner 
who has hepatitis A. 
 
Onset of symptoms is usually abrupt 
with fever, malaise, anorexia, nausea 
and abdominal discomfort followed by 
jaundice a few days later. Children are 
often asymptomatic. Upon recovery, a 
person is immune to hepatitis A.  
 
 Case total of 6 represents a decrease 
from 7 cases in 2010 
 The 2006-2010 median number of 
cases per year was 7 
 Median age was 29 years 
 Age range was 8 to 51 years 
 
Washing hands after using the 
bathroom, changing a diaper, or before 
preparing or eating food can help 
prevent infection. Hepatitis A can be 
prevented through vaccination. The two 
dose vaccine series is recommended for 
all children at 12 months of age and for 
persons who are more likely to get 
hepatitis A or become seriously ill if 
they get hepatitis A.  The vaccine is also 
recommended for some travelers and for 
close contacts of newly arriving 
international adoptees. 
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Hepatitis B, acute 
2011 Case Total 8 
Maine Rate 0.6 per 100,000 
U.S. rate (2010) 1.1 per 100,000 
Acute Hepatitis B Incidence, Maine and US, 
2007-2011
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Hepatitis B is a liver disease caused by 
the hepatitis B virus. Acute hepatitis B 
infection occurs within the first six 
months after someone is exposed to the 
virus. In some cases, acute infection can 
lead to chronic infection. The younger 
the age at time of infection, the greater 
the likelihood of progressing to chronic 
hepatitis B infection. 
 
Hepatitis B virus can be transmitted 
through exposure to blood or body 
fluids from an infected person (needle 
sticks and other sharps exposures, 
sharing hypodermic syringes for drug 
injection), through sexual contact with 
an infected person, or from an infected 
mother to her child during childbirth.  
Sexual transmission is especially 
common among men who have sex with 
men.  
 
Symptoms include anorexia, abdominal 
discomfort, nausea and vomiting 
followed by jaundice. Many young 
children and immunosuppressed adults 
do not develop symptoms. 
 
 Case total of 8 represents a decrease 
from 13 cases in 2010 
 The 2006-2010 median number of 
cases per year was 15  
 Median age was 46 years 
 Age range was 29 to 57 years 
 Cases were 13% female and 87% 
male 
 
Hepatitis B can be prevented by 
vaccination as well as by not sharing 
needles and other drug injecting 
equipment, using sterile needles and 
syringes, and using condoms.  
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Hepatitis B, chronic 
2011 Case Total 105 
Maine Rate 7.9 per 100,000 
U.S. rate (2010) Not available 
Newly Reported Cases of Chronic 
Hepatitis B, Maine, 2007-2011
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Hepatitis B is a liver disease caused by 
the hepatitis B virus. Chronic hepatitis 
B virus infection occurs when an 
infected person does not clear the virus 
within the first 6 months of infection. 
 
Chronic hepatitis B is a serious disease 
that can result in long-term health 
problems, such as cirrhosis (scarring) of 
the liver, liver cancer, liver failure, and 
even death. Many people do not have 
symptoms and may not know they are 
infected, but can still spread the disease 
to others. 
 
Hepatitis B virus can be transmitted 
through exposure to blood and or body 
fluids from an infected person (needle 
sticks and other sharps exposures, 
sharing hypodermic syringes for drug 
injection), through sexual contact with 
an infected person, or from an infected 
mother to her child during childbirth.  
Sexual transmission also occurs among 
men who have sex with men.  
 
 Case total of 105 represents a 
increase from 101 cases in 2010 
 Median age was 39 years 
 Age range was 10 to 76 years 
 Cases were 33% female and 67% 
male 
 
Transmission of hepatitis B virus can be 
prevented through test ing and 
vaccination of susceptible household 
and sexual contacts of identified cases. 
Transmission can also be prevented by 
not sharing needles or other drug 
injecting equipment, using sterile 
needles and syringes, and using 
condoms. 
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Hepatitis C, acute 
2011 Case Total 12 
Maine Rate 0.9 per 100,000 
U.S. rate (2010) 0.3 per 100,000 
Hepatitis C Incidence, Maine and US, 2007-2011
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Hepatitis C is a liver disease caused by 
the hepatitis C virus (HCV). Acute 
hepatitis C is a short term illness that 
occurs within the first 6 months after 
someone is exposed. HCV is spread 
when blood from a person infected with 
HCV enters the body of someone who is 
not infected. Many people become 
infected with HCV by sharing needles 
or other injection drug equipment. 
 
Persons with acute or newly acquired 
HCV infection are usually 
asymptomatic or have mild symptoms. 
Approximately 20%–30% of persons 
with acute infection experience fatigue, 
abdominal pain, poor appetite, and/or 
jaundice.  The average time period from 
exposure to symptom onset is 4–12 wks 
(range: 2–24 wks). Other symptoms of 
acute infection include: dark urine, clay-
colored stool,  nausea, vomiting, and 
joint pain. 
 Case total of 12 represents an 
increase from 2 cases in 2010, which 
may be related to a change in case 
definition  
 The 2006-2010 median number of 
cases per year was 2 
 Median age was 38 years 
 Age range was 21 to 52 years 
 Cases were 50% female and 50% 
male. 
 
To prevent acute HCV infection, do not 
share needles or equipment used to 
inject drugs. Do not share personal 
hygiene items.  Use licensed tattooists 
and body piercers. Use condoms to  
reduce the already low risk of sexual 
transmission.  
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Hepatitis C, past or 
present infection 
2011 Case Total 1184 
Maine Rate 89.1 per 100,000 
U.S. rate (2010) N/A 
Reported Cases of Past or Present Hepatitis C 
Infection, Maine, 2007-2011
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Hepatitis C is a liver disease caused by 
the hepatitis C virus (HCV). Chronic 
hepatitis C is a long-term illness that 
occurs when hepatitis C virus remains 
in a person’s body. Over time it ca lead 
to serious liver disease. HCV is spread 
when blood from a person infected with 
HCV enters the body of someone who is 
not infected. Many people become 
infected with HCV  by sharing needles 
or other injection drug equipment. 
 
Most people with chronic HCV do not 
have any symptoms. In many cases, 
symptoms only appear when liver 
problems develop. HCV is often 
detected during routine blood tests to 
measure liver function and liver enzyme 
levels. A hepatitis C positive report is 
defined as the presence of any positive 
serologic marker for hepatitis C 
infection.  
 
 Case total of 1184 represents an  
    increase from 1142 cases in 2010 
 Age range was 3 to 96 years 
 Highest number of cases reported was 
among people 25-34 years (296), 
slightly higher than the number of 
cases reported among people 45-54 
(290)  
 Overall, cases were 63% male and 
37% female. However, females 
exceeded males in the 15-24 and 65 
and older age groups. 
 
People with chronic HCV should be 
monitored regularly by an experienced  
healthcare provider. They should avoid 
alcohol and  check with a health 
professional before taking any 
prescription pills, supplements, or over-
the-counter medications, as these can 
poten t i a l ly  damage  the  l iver . 
Vaccination against hepatitis A and 
hepatitis B is also recommended. 
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HIV* 
2011 Case Total 54 
Maine Rate 4.1 per 100,000 
U.S. rate (2010) 19.7 per 100,000 
Newly Identified HIV Diagnoses, Maine and US, 
2007-2011
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Human immunodeficiency virus (HIV) 
is a virus that is responsible for HIV 
disease and acquired immuno-
deficiency syndrome (AIDS). AIDS 
typically presents as the late clinical 
stage of HIV infection. HIV is 
transmitted  from person to person 
through unprotected penile-vaginal or 
penile–anal intercourse with an infected 
person; the use of HIV contaminated 
needles and syringes; from infected 
mother to infant during pregnancy, 
delivery, or breast-feeding; and 
transfusion of infected blood or its 
components. In Maine, the most 
common mode of HIV transmission is 
through unprotected penile-anal 
intercourse among men.  
 
 Case total of 54 represents a decrease 
from 59 cases in 2010  
 The 2006-2010 median number of 
cases per year was 52 
 Age range was 22 years to 66 years  
 Majority of cases were male (80%) 
 52% of cases reported risk factor of 
males who have sex with other males 
  
HIV transmission can be prevented by 
the use of latex or polyurethane 
condoms and dental dams during anal, 
vaginal, and oral sex.  It is equally 
important to always use clean needles 
and injection equipment when injecting 
any substance.  HIV testing, counseling, 
and referral services are offered by 
various agencies and programs 
dedicated to HIV prevention and 
treatment in Maine.   
*Includes all newly identified HIV infections, including those simultaneously diagnosed as new AIDS cases.  
Mode of Transmission New  
Diagnoses 
Men who have sex with men (MSM) 29 
Injection drug users (IDU) 1 
MSM and IDU 0 
Heterosexual contact with at-risk partners 4 
Heterosexual, no at-risk partners disclosed 12 
Undetermined 8 
Received contaminated  blood products 0 
Child born to mother with HIV 0 
Reported Transmission Risk Factors Among Persons 
Diagnosed with HIV, 2011 
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Legionellosis 
2011 Case Total 18 
Maine Rate 1.4 per 100,000 
U.S. rate (2010) 1.1 per 100,000 
Legionellosis Incidence, Maine and US, 
2007-2011
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Legionellosis (or Legionnaire’s disease) 
is a serious and sometimes fatal form of 
pneumonia. Legionella bacteria are 
widespread in natural, industrial and 
recreational water sources.  The bacteria 
grow best in warm, stagnant water.  
They can be found in creeks and ponds, 
hot and cold water taps, hot water tanks, 
water cooling towers, and condensers of 
large air-conditioning systems.  People 
get legionellosis when they breathe in a 
mist or vapor that is contaminated with 
the bacteria.  Persons at high risk of 
getting legionellosis include those who 
are middle aged or older, smoke, have 
chronic lung disease, or weakened 
immune systems due to cancer, kidney 
failure, diabetes or HIV infection. 
 
Symptoms include high fever, chills, 
muscle aches, headaches, cough and 
pneumonia.  Legionellosis is treatable 
with antibiotics.  
 
• Case total of 18 represents an 
increase from 12 cases in 2010 
• The 2006-2010 median number of 
cases per year was 11 
• Median age was 54 years 
• Age range was 26 to 89 years 
• Cases were 39% female and 61% 
male 
 
P r even t i on  d epends  on  good 
maintenance of possible water sources 
of infection (water tanks, water systems, 
fountains, etc.). This includes regular 
cleaning, disinfecting and applying  
other physical (temperature) or 
chemical measures to minimize growth.  
Applying such controls at hospitals, 
industrial sites, hotels and recreation 
centers will reduce the risk of water 
contamination. 
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Listeriosis 
2011 Case Total 4 
Maine Rate 0.3 per 100,000 
U.S. rate (2010) 0.3 per 100,000 
Listeriosis Incidence, Maine and US, 2007-2011
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Listeriosis is a bacterial illness, caused 
by Listeria monocytogenes. Infection 
may cause sepsis and meningitis.  
Listeriosis is frequently linked to ready-
to-eat meats (such as paté and 
refrigerated smoked seafood), deli 
meats, soft cheeses and raw milk. 
Pregnant women are at highest risk for 
severe outcomes as an infection  
acquired during pregnancy can be 
transmitted to the fetus.  Also at risk are 
the elderly and individuals with 
significant health conditions like cancer, 
diabetes, liver disease, immune system 
problems, or multiple medical 
conditions.  
 
Symptoms include fever, headache, 
nausea, fatigue and disorientation.  
Listeriosis may cause spontaneous 
abortion.  
 
• Case total of 4 represents an increase 
from one case in 2010 
• The 2006-2010 median number of 
cases per year was 4  
• Median age was 78 years 
• Age range was 49 to 89 years 
• All 4 cases were hospitalized 
 
Listeria bacteria are able to multiply in 
contaminated foods even during 
refrigeration.  Poultry or meat 
(including hot dogs) should not be 
consumed without following proper 
cooking instructions. Raw milk or foods 
made from raw milk should be avoided.  
Pregnant women and people with 
weakened immune systems should 
avoid eating such foods as ready-to-eat 
meats, hot dogs, soft cheeses, and 
refrigerated smoked seafood. 
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Lyme Disease 
2011 Case Total 1,006 
Maine Rate 75.7 per 100,000 
U.S. Rate (2010) 9.8 per 100,000 
Lyme Disease Incidence, Maine and US, 
2007-2011
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Lyme disease, Maine’s most common 
vectorborne disease in humans, is 
caused by the bacterium Borrelia 
burgdorferi. The disease is transmitted 
via the bite of an infected deer tick 
(Ixodes scapularis) and symptoms are 
generally visible between 3 and 30 days 
after the initial bite. Early symptoms 
include the characteristic “bulls eye” 
rash, fever, headache, joint and muscle 
pain, fatigue. Later symptoms include 
arthritis, Bell’s palsy and other cranial 
nerve palsies, meningitis, and carditis.  
 
The case definition for classifying cases 
changed effective January 1, 2008,  and 
included a probable case definition 
which led to a higher case count than 
previous years. 
 
 Case total of 1,006 represents an 
increase from 751 cases in 2010 
 The 2006-2010 median number of 
cases per year was 751 
 Median age was 45 years 
 Age range was 11 months to 93 years 
 Cases were 43% female and 57% 
male 
 Cases were greatest in York (19.7%) 
and Cumberland (27.3%) counties 
 
Although there is no vaccine for Lyme 
disease, risk can be greatly reduced by 
avoiding tick habitats, using EPA 
approved repellents (such as DEET), 
wearing long sleeves and pants, and 
checking for ticks after spending time in 
tick habitat. Landscape management 
and control of deer herds can also allow 
communities to better protect residents 
from Lyme disease. 
 
For more information about submitting 
a tick for identification (not testing for 
Lyme disease) visit www.mmcri.org/
lyme.    
Lyme Disease by Month of Report, Maine, 2011
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Meningococcal Disease 
2011 Case Total 5 
Maine Rate 0.4 per 100,000 
U.S. rate (2010) 0.3 per 100,000 
Meningococcal Disease Incidence, Maine and 
US, 2007-2011
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Meningococcal disease is an infection 
caused by Neisseria meningitidis, a 
gram-negative diplococcus bacterium. 
Meningococcal disease presents most 
commonly as meningitis and/or 
meningococcemia that may progress 
rapidly to purpura fulminans, shock and 
death. Transmission of meningococcal 
disease most often occurs through direct 
contact with respiratory secretions from 
the nose or throat of a person with the 
infection.  
 
Symptoms include fever, headache, and 
stiff neck for meningitis and rash and 
sepsis for meningococcemia.  The 
symptoms are indistinguishable from 
other pathogens causing  meningitis. 
 
• Case total of 5 represents the same 
number of cases as 2010 
• The 2006-2010 median number of 
cases per year was 6  
• Median age was 47 years 
• Age range was 3 to 103 years 
• Cases were 40% female and 60% 
male 
• Serogroups identified include: A (1), 
B (2), W-135 (1), Y (1) 
 
There are at least thirteen known 
Neisseria meningitidis serogroups, and 
there is currently a vaccine available for 
the four serogroups that cause the 
majority of infections (serogroups A, C, 
Y, and W-135). The vaccine is 
recommended for all adolescents, 
college students, military recruits, 
overseas travelers, and any other 
persons at increased risk of infection. 
To prevent the spread of disease, 
chemoprophylaxis is available for 
persons who have close and direct with 
a person with the infection. 
Meningococcal Disease by Age and Gender, 
Maine, 2011
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MRSA, invasive 
2011 Case Total 121 
Maine Rate 9.1 per 100,000 
U.S. rate (2010) Not reportable 
Invasive MRSA Incidence, Maine, 2007-2011
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Since 2008, all cases of invasive 
methicillin-resistant Staphylococcus 
aureus (MRSA) are reportable, regardless 
of whether community-acquired or 
healthcare associated.    
 
MRSA is caused by a strain of bacteria 
which is resistant to the antibiotic 
methicillin and many of the antibiotics 
commonly used to treat staphylococcal 
infections. MRSA is becoming more 
common in the community, usually 
presenting as a skin or soft tissue 
infection, considered a non-invasive 
infection.  Invasive MRSA occurs when 
the bacteria  infect internal systems and 
are isolated from a normally sterile site 
(such as blood, CSF, pleural fluid or joint 
fluid) 
 
Persons with weakened immune systems, 
the elderly, and those with invasive 
medical devices are at increased risk of 
invasive MRSA infections. 
 
 Case total of 121 represents an increase 
from 90 cases in 2010 
 Median age was 61 years 
 Age range was 2 months to 95 years 
 Cases were 38% female and 62% male 
 
To reduce MRSA transmission cover 
wounds with clean dry bandages; wash 
hands frequently with soap and warm 
water; use disinfectants effective against 
S. aureus; avoid sharing personal items 
such as towels, washcloths, razors and 
clothing; tell your healthcare provider if 
you had contact with someone with 
MRSA; and avoid contact sports and 
other skin-to-skin contact until your 
infection heals. Seek medical care 
immediately to identify infection early 
and receive treatment for invasive MRSA 
infection. 
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Mosquito Borne Infections 
Mosquitoes are found around the world.  Female 
mosquitoes suck blood, making them an 
important disease vector.  There are 45 species of 
mosquitoes in Maine, some of which are capable 
of carrying diseases including EEE and WNV. 
 
Eastern Equine Encephalitis (EEE) 
EEE is a mosquito-borne viral disease that occurs 
in the eastern half of the United States where it 
can cause disease in humans, horses, and some 
birds.  Most persons infected with EEE will have 
no obvious symptoms.  In those persons who do 
develop illness, symptoms of EEE range from 
mild-flu like illness to inflammation of the brain, 
coma, and death.  EEE is one of the most serious 
mosquito-borne diseases in the United States 
because of its high mortality rate. 
 
In 2011, 10 turkeys tested positive for EEE by 
serology in Maine.  There were no human cases 
and no mosquito pools tested positive for EEE.  
 
West Nile Virus (WNV) 
WNV occurs throughout the United States and 
can cause disease in humans, birds, and other 
mammals.  Many persons infected with WNV 
will have no obvious symptoms.  In those 
persons who do develop illness, symptoms of 
WNV include:  headache, high fever, altered 
mental state, tremors, convulsions, and rarely 
paralysis.  WNV can also cause meningitis and/
or encephalitis and can be fatal. 
 
In 2011, no mosquito pools, birds, humans or 
other mammals tested positive for WNV in 
Maine. 
 
Malaria 
Malaria is a serious and sometime fatal disease 
caused by a parasite that commonly infects a 
certain type of mosquito.  Symptoms may 
include high fevers, shaking chills, flu-like 
illness, headache, muscle aches, tiredness, 
nausea, vomiting and diarrhea.  Malaria is 
uncommon in the United States. 
In 2011, there were six cases of malaria reported in 
Maine individuals who had a history of travel 
outside the US (Afghanistan, Iraq, Uganda, and 
India).   
 
Dengue Fever 
Dengue is a disease caused by a virus transmitted 
by the bite of an infected mosquito.  Symptoms of 
dengue fever include high fever, severe headache, 
backache, joint pain, nausea and vomiting, eye pain 
and rash. 
 
In 2011, there were no cases of Dengue fever 
reported to the state.  Dengue virus is not common 
in the United States, but has been locally acquired 
in Florida, Texas and Hawaii.  
 
Prevention  
To decrease risk of contracting a mosquito-borne 
disease, measures should be taken to prevent 
mosquito bites: 
 Use an EPA approved repellent. Products 
containing DEET, IR3535, picaridin or oil of 
lemon eucalyptus can be applied to exposed 
skin, and permethrin containing products can 
be applied to clothing.  Make sure to follow the 
instructions on the product’s label when using 
repellents or other pesticides 
 Wear long sleeve shirts and long pants when 
possible or when mosquitoes are abundant 
 Protect babies with mosquito netting 
 When mosquitoes are especially abundant, stay 
indoors 
 Mosquito proof your house by fixing or 
installing window screens and screen doors 
 Control mosquito populations around your 
home by cleaning gutters and removing or 
emptying objects that contain still water where 
mosquitoes can lay eggs such as old tires, old 
cans,  and plastic tarps  
 Empty water from flower pots, pet dishes, 
birdbaths, rain barrels, and buckets at least 
once a week 
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Pertussis 
2011 Case Total 205 
Maine Rate 15.4 per 100,000 
U.S. rate (2010) 8.9 per 100,000 
Pertussis Incidence, Maine and US, 2007-2011
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Pertussis (whooping cough) is a 
bacterial infection of the respiratory 
tract caused by Bordetella pertussis.  
Prior to vaccine licensure pertussis was 
a common childhood disease associated 
with a high mortality rate. High 
pertussis vaccination rates are 
associated with lower numbers of 
pertussis cases. 
 
Symptoms include an irritating cough 
lasting at least 2 weeks with paroxysm, 
whoop, and post-tussive vomiting. 
 
 Case total of 205 represents an  
increase from 53 cases in 2010 
 The 2006-2010 median number of 
cases per year was 80 
 Median age was 10 years 
 Age range was 1 month to 79 years 
 Cases were 54% female and 46% 
male 
 Piscataquis and Penobscot counties 
had the highest incidence 
 
In 2011, clusters of illness occurred in 
schools, camps, sport teams and 
workplaces, mostly in Penobscot 
County (67% of all cases). Federal CDC 
collaborated with Maine to assess 
vaccine effectiveness and acceptability 
in Penobscot County. 
 
Vaccination is available and part of 
routine childhood immunizations.  
There are two pertussis vaccines (DTaP 
and Tdap). The ACIP recommends all 
persons 11 years and older receive Tdap 
in place of one tetanus booster. 
 
 
*Onset date missing for 3 cases 
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Rabies, Animal 
2011 Case Total 66 
Maine Rate N/A 
U.S. Count (2010) 6,155 
Animal Rabies, Maine, 2002-2011
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Rabies is a zoonotic disease caused by a 
virus that affects the nervous system 
(brain and spinal cord). Rabies in humans 
is rare in the United States. The vast 
majority of rabies infections are found in 
wild animals, including raccoons, skunks, 
bats, and foxes. Humans usually get 
rabies from the bite of a rabid animal.  It 
is also possible, but quite rare, for people 
to get rabies if infectious material from a 
rabid animal, such as saliva or neural 
tissue, gets directly into their eyes, nose, 
mouth or a wound.  Because rabies has 
occurred in people who have very close 
contact with bats without an apparent bite, 
this type of contact is also considered a 
risk and should be evaluated by a 
healthcare provider. 
 
When a human is infected with rabies the 
virus infects the central nervous system. 
The earliest symptoms include fever and 
general discomfort. As the disease 
progresses symptoms may include 
difficulty sleeping, anxiety, confusion, 
hallucinations, excessive drooling, 
difficulty swallowing, and fear of water. 
Death generally follows a few days after 
the onset of symptoms. 
 
 Case total of 66 animal rabies cases 
represents an increase from 62 cases 
in 2010 
 The 2006-2010 median number of 
cases per year was 64 cases 
 The last reported case of human 
rabies in Maine was in 1937 
 34 persons recommended to receive 
PEP after exposure to a rabid animal 
 110 persons reported for receiving 
PEP after exposure to a suspect rabid 
animal that was not available for 
testing 
 
Testing an animal for rabies requires 
central nervous system or brain tissue, 
which must be obtained from the animal 
after it is deceased. Using direct 
fluorescent antibody testing, the state’s public health 
laboratory can determine whether wild or domestic animals 
that exposed a human or domestic animal are infected with the 
virus. In 2011, an unvaccinated domestic horse tested positive 
for rabies after exposure to a raccoon. 
 
If it is determined that a human was exposed to an infected 
animal, a course of post-exposure prophylaxis (PEP) is 
recommended. Generally, rabies PEP consists of a course of 
immune globulin and vaccine over a 14 day period.   
 
Human rabies cases in the United States are rare. Increased 
public awareness of rabies may reduce the number of 
exposures. Though rabies is generally found in wild animals, 
it is important to keep domestic animals up to date on rabies 
vaccination. The use of human  rabies PEP after an exposure 
is effective in preventing disease. 
Positive Rabies Results by Species, Maine, 2011 
Animal Number 
Positive 
Raccoon 32 
Skunk 12 
Fox 11 
Bat 5 
Cat (feral) 2 
Sheep 2 
Horse 1 
Bobcat 1 
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Salmonellosis 
2011 Case Total 134 
Maine Rate 10.1 per 100,000 
U.S. rate (2010) 17.6 per 100,000 
Salmonellosis Incidence, Maine and US, 
2007-2011
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Salmonellosis is a gastrointestinal 
illness of varying severity caused by 
Salmonella bacteria.  Severity of 
symptoms depends on the age and 
overall health of the person infected, 
serotype of Salmonella and the site of 
infection. Salmonella is transmitted 
through the ingestion of contaminated 
meat, poultry, eggs, unpasteurized 
dairy, and fresh produce. Handling of 
reptiles, chicks, domestic birds, and pets 
can also lead to transmission. 
 
The symptoms can include fever, 
cramping, diarrhea, nausea, and 
vomiting.  
 
 Case total of 134 represents an 
increase from 133 cases in 2010 
 The 2006-2010 median number of 
cases per year was 138  
 Median age was 47 years 
 Age range was 4 months to 94 years 
 Cases were 52% female and 48% 
male 
 125 of 134 (93%) cases were 
laboratory confirmed 
 The most commonly seen types of 
Salmonella were Enteritidis and  
Typhimurium  
 
The best way to reduce the risk of 
salmonellosis is to wash produce, avoid 
consuming unpasteurized products, and 
follow proper cooking instructions. 
Individuals having contact with reptiles 
(such as snakes, lizards, turtles, frogs, 
iguanas, etc.), birds, and farm animals 
should wash their hands immediately 
after handling these animals. 
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Shiga toxin-producing  
E. coli (STEC) 
2011 Case Total 28 
Maine Rate 2.1 per 100,000 
U.S. rate (2010) 1.8 per 100,000 
STEC Incidence, Maine and US, 2007-2011
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Escherichia coli (E. coli) are common 
bacteria that live in the digestive tract, 
some cause serious infection and some 
do not. Transmission of Shiga toxin-
producing E. coli (STEC) is through 
consumption of food or water 
contaminated with fecal matter or 
through contact with farm animals. 
Commonly implicated food items 
include undercooked meats, raw 
vegetables, and unpasteurized products.  
 
STEC may cause severe illness. 
Symptoms include abdominal cramping, 
bloody diarrhea and a rare complication, 
hemolytic uremic syndrome (HUS), 
which can damage red blood cells and 
the kidneys. 
 
 Case total of 28 represents an 
increase from 21 cases in 2010 
 The 2006-2010 median number of 
cases per year was 26 
 Median age was 23 years 
 Age range was 1 to 87 years 
 Cases were 54% female and 46% 
male 
 24 of 28 (86%) cases were laboratory 
confirmed 
 21% of laboratory confirmed cases 
were O157:H7  
 Two cases of hemolytic uremic 
syndrome (HUS) with symptoms of 
diarrhea were reported, no E. coli 
isolated from specimens 
 
STEC prevention measures include: 
handwashing, particularly before and 
after cooking and after contact with 
animals; thoroughly cooking meats; 
washing fresh fruits and vegetables; 
avoiding raw dairy products and 
unpasteur ized juices;  avoiding 
consumption of untreated water; and 
avoiding cross-contamination of food 
items. 
*Onset date missing for one case 
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Shigellosis 
2011 Case Total 32 
Maine Rate 2.4 per 100,000 
U.S. rate (2010) 4.8  per 100,000 
Shigellosis Incidence, Maine and US, 2007-2011
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Shigellosis is a gastrointestinal illness 
caused by Shigella bacteria. Shigella is 
highly infectious and can easily be passed 
from one person to another through the 
fecal-oral route. Shigellosis can be 
transmitted by eating contaminated food, 
and drinking, swimming in or playing 
with contaminated water. Outbreaks of 
Shigella have also occurred among men 
who have sex with men. 
 
Symptoms include fever, stomach 
cramping and severe diarrhea which may 
be bloody. Children, especially toddlers 
aged 2 to 4 years, are most likely to get 
shigellosis. 
 
 Case total of 32 represents an increase 
from 8 cases in 2010 
 The 2006-2010 median number of 
cases per year was 8 
 Median age was 11 years 
 Age range was 1 to 71 years 
 Cases were 69% female and 31% male 
 20 of 32 (63%) cases were laboratory 
confirmed 
 Shigella sonnei and flexneri were 
identified 
 6/8 (75%) of non-outbreak related 
cases had travel to a foreign country 
during exposure period 
 24/32 (75%) cases were associated with 
a community wide outbreak with 
matching Shigella organisms 
 
To prevent shigellosis, practice good hand 
hygiene, avoid consuming unpasteurized 
milk products,  use filtered, clean water, 
and store foods properly.  Infected 
persons who are employed in childcare, 
healthcare, or food handling are restricted 
from work until infection clears and there 
is no evidence of Shigella in stool 
specimens. Shigellosis is more common 
in the developing world and travelers 
should take extra precautions. 
*Onset date missing for one case 
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Streptococcus pneumoniae,  
invasive  
2011 Case Total 136 
Maine Rate 10.2 per 100,000 
U.S. rate (2010) 5.4 per 100,000 
Drug Resistant Invasive S. pneumoniae 
Incidence, Maine and US, 2007-2011*
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Starting in 2010, all cases of invasive 
disease were investigated and reported. 
*Prior to 2010 only drug resistant cases 
and illness in children under 5 years were 
reported to federal CDC. 
 
Invasive pneumococcal disease occurs 
when the Streptococcus pneumoniae 
bacterium infects the blood, lungs, or 
brain.  Disease is transmitted from person 
to person through droplets when an 
infected person coughs or sneezes.  Types 
of illness include bacteremia, meningitis, 
and pneumonia.  There are over 90 
different serotypes of S. pneumoniae, but 
the majority of pneumococcal disease is 
caused by a few common serotypes.   
 
Persons at risk of pneumococcal disease 
include young children, adults 65 years of 
age or older, persons with certain 
underlying medical conditions, persons 
with weakened immune systems, and 
those in congregate settings such as 
daycare and long-term care facilities. 
 
 Case total of 136 represents an increase 
from 130 in 2010 
  32 cases were drug resistant (resistant 
to at least one tested antibiotic) 
 Median age for  invasive cases was 60 
years 
 Age range for invasive cases was 1 to 
105 years 
 Cases were 45% female and 55% male 
 4 cases were in children under the age 
of five (none were drug resistant) 
 
Pneumococcal disease can be prevented 
through routine vaccination of infants and 
children under five years with the 
pneumococcal conjugate vaccine 
(PCV13) and vaccination of adults and 
children over the age of two who are at 
high risk of infection with the 
pneumococcal polysaccharide vaccine 
(PPV23).  
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 Early Syphilis 
2011 Case Total 20 
Maine Rate 1.5 per 100,000 
U.S. rate (2010) 8.9 per 100,000 
Early Syphilis Incidence, Maine and US,                         
2007-2011
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Syphilis is a sexually transmitted 
disease (STD) caused by the bacterium 
Treponema pallidum.  It has often been 
called “the great imitator” because so 
many of the signs and symptoms of 
syphilis are like those of other diseases.  
 
Early syphilis is defined as disease that 
occurs within the first year of infection.  
This is inclusive of the primary, 
secondary, and early latent stages of the 
disease.   
 
Syphilis is primarily spread through 
direct contact with a primary syphilis 
lesion.  Lesions typically occur on the 
external genitals, vagina, and around the 
anus, but are also seen on the lips and in 
the mouth.  Transmission primarily 
occurs during vaginal, anal, or oral sex. 
Disease transmission can also occur 
during the infectious period of the 
secondary stage, via the condylomata 
lata (raised moist papules) on the genital 
area or mucous patches in the mouth.  
Pregnant women with syphilis can pass 
it to their baby.  Genital lesions caused 
by syphilis make it easier to transmit 
and acquire HIV infection.   
 
• Case total of 20 represents a decrease 
from 39 cases in 2010 
• The 2006-2010 median number of 
cases per year was 16 
• 19 (95%) of cases were male, with 
only one female case (5%)  reported 
 
Many individuals infected with syphilis reach a latent stage 
and have no symptoms for years, but they are still at risk for 
later complications (damage to internal organs, nerve 
damage, blindness and dementia) and death if not treated.  
 
Syphilis transmission can be prevented by the use of latex or 
polyurethane condoms and dental dams during anal, vaginal, 
and oral sex. Prevention and control efforts include targeted 
awareness messaging  (including the internet) and disease 
intervention activities for all early syphilis cases. Disease 
intervention activities include ensuring adequate treatment, 
notifying partners of potential exposure, and identification of 
public sex environments that outreach educators can target in 
their work.   
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Tuberculosis 
2011 Case Total 9 
Maine Rate 0.7 per 100,000 
U.S. rate (2010) 3.6 per 100,000 
Tuberculosis Incidence, Maine and US, 
2007-2011
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Tuberculosis (TB) is a communicable 
disease caused by the bacterium, 
Mycobacterium tuberculosis.  It is 
spread through the air by airborne 
particles called droplet nuclei that are 
expelled from the lungs when a person 
who has infectious TB coughs, sings or 
sneezes.  TB infection begins when the 
mycobacterium is inhaled into the lung 
and begins to multiply.  Usually, the 
body is able to contain the infection so 
that disease does not develop. This is 
known as latent TB infection (LTBI) 
and is not infectious to others.  
 
TB can cause infection  in the lung 
(pulmonary), which is considered 
infectious to others. TB also causes 
infection outs ide of the  lung 
(extrapulmonary), which is not 
infectious. 
 
• Case total of 9 represents an increase 
from 8 cases in 2010 
• Lowest case rate in the country in 
2011 
• The 2006-2010 median number of 
cases per year was 9  
• Median age was 70 years 
• Age range was 19 to 90 years 
• Cases were 67% female and 33% 
male 
• 5 of 9 cases (56%) were foreign born 
• In 5 contact investigations, 78% of 
identified contacts were evaluated; 
range of 55% - 100% for individual 
cases 
• Of 432 LTBI reports, 81% were 
foreign born 
 
All cases are evaluated by a TB 
consultant physician and are placed on 
directly observed therapy (DOT) 
administered by Public Health Nurses.  
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Varicella 
2011 Case Total 226 
Maine Rate 17.0 per 100,000 
U.S. rate (2010) 5.0 per 100,000 
Varicella Incidence, Maine and US, 2007-2011
0
5
10
15
20
25
30
2007 2008 2009 2010 2011
Year
C
as
es
 p
er
 1
00
,0
00
Maine US
Varicella by Month, Maine, 2011
0
10
20
30
Ja
n
Fe
b
Ma
r
Ap
r
Ma
y
Ju
n Ju
l
Au
g
Se
p Oc
t
No
v
De
c
Month
C
as
es
Varicella (chickenpox) is a highly 
contagious viral disease of which 
humans are the only source of infection.   
In most illness includes an itchy skin 
rash that looks like blisters, covering the 
body but  more evident on the face, 
scalp, and abdomen. The majority of 
infected individuals develop a fever just 
before or when the rash appears.  
 
Person-to-person transmission occurs 
primarily through direct contact with 
respiratory tract secretions of infected 
individuals  and is  t ransmitted 
occasionally via the airborne route.  
Adolescents and adults are  at higher 
risk for severe disease which could 
include pneumonia, bacterial infection 
of the skin and swelling of the brain.  
 
 Case total of 226 represents a 
decrease from 247 cases in 2010 
 Overall the greatest incidence was 
during the fall and spring months 
while school was in session 
 Nationally varicella incidence is 
reported to be an underestimate of 
true incidence 
 
Varicella vaccine is a live attenuated 
viral vaccine.  A two-dose series is 
estimated to be more than 90% effective 
in preventing infection. Federal CDC 
and ACIP recommend that all children 
receive 2 doses of varicella vaccine. 
Breakthrough infection has been 
reported in vaccinated individuals.  
 
Mandatory vaccination for varicella 
(one dose) began in 2003 and is now a 
requirement for school admission.   
51
Vibriosis 
2011 Case Total 4 
Maine Rate 0.3 per 100,000 
U.S. rate (2010) 0.3 per 100,000 
Vibriosis Incidence, Maine and US, 2007-2011
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Vibriosis is an infection of variable 
severity characterized by diarrhea and 
vomiting, primary septicemia, or wound 
infections. Vibrio parahaemolyticus, 
associated with ingestion of raw or 
undercooked seafood, and Vibrio 
alginolyticus, associated with wounds 
and water contact, are the primary 
causes of vibriosis in Maine. 
 
 Case total of 4 represents a decrease 
from 5 cases in 2010 
 The 2006-2010 median number of 
cases was 4  
 Median age was 55 years 
 Age range was 32 to 90 years 
 Cases were 25% female and 75% 
male 
 V i b r i o  a l g i n o l y t i c u s ,   
parahaemolyticus,  and fluvialis were 
isolated. 
 
Vibrio infections caused by V. 
parahaemolyticus can be prevented by 
thoroughly cooking seafood, especially 
oysters.  Wound infections can be 
prevented by avoiding exposure of open 
wounds to seawater.   Maine CDC 
works closely with the Maine 
Department of Marine Resources when 
persons with vibriosis report having 
exposures to shellfish or other marine 
sources of illness.  
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Influenza 
Influenza is a viral illness that typically occurs 
during the winter months. It is characterized by 
the abrupt onset of constitutional and 
respiratory signs and symptoms such as fever, 
headache, non-productive cough, sore throat, 
and runny nose.  Influenza is spread from 
person to person primarily through coughing 
and sneezing of infected persons.  Influenza 
can be diagnosed through laboratory testing.  
Influenza-like illness (ILI) is defined as fever 
greater than or equal to 100°F (37.8°C) AND 
cough and/or sore throat in the absence of a 
known cause.  
 
The purpose of influenza surveillance is to 
inform influenza prevention and control policy.  
Maine CDC conducted influenza surveillance 
in collaboration with thirty health care 
providers, four hospitals, three laboratories, 
one city vital records office, and twenty four 
hospital emergency departments during the 
reporting period from October 2, 2011 to May 
19, 2012.  This report summarizes 2011-12 
influenza surveillance by key indicators.   
 
 
Influenza Surveillance in Maine 
 
Outbreaks 
Outbreaks of influenza or influenza-like illness are 
reportable by law in Maine.  The definition used to 
recognize outbreaks of influenza-like illness varies 
by setting.  During the 2011-12 season, a total of 
ten outbreaks of influenza were reported in Maine. 
This is a decrease from the 2010-11 season when 
61 outbreaks were reported. Of the 10 outbreaks, 8 
were in long-term care facilities, 1 in K-12 schools, 
and 1 in a university setting.  Outbreaks occurred in 
four of the eight districts in the state (Cumberland, 
Penquis, Western and York).   
 
Death Certificates 
The vital records office of Bangor reported the 
number of death certificates in which pneumonia 
and/or influenza were mentioned as the primary or 
secondary cause of death.  Data reported represent 
deaths that occurred in the reporting area, not the 
residence of the deceased.  During the 2011-12 
season, a total of 751 deaths were reported by this 
vital records office.  Of these 110 (14.6%) were 
attributed to pneumonia or influenza.   
 
Pediatric Fatalities 
Health care providers and the Office of the Medical 
Examiner report deaths in persons aged 18 years or 
younger associated with laboratory-confirmed 
influenza to Maine CDC.  No influenza-associated 
pediatric deaths were reported during the 2011-12 
influenza season. 
Appendix A 
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Influenza Season 2011—2012 
Outpatient influenza-like illness (ILI) 
Data on outpatient visits for ILI  was 
collected through the U.S. Outpatient 
Influenza-like Illness Surveillance 
Network (ILINet), a collaborative effort 
between federal CDC, Maine CDC, and 
local health care providers.  During the 
2011-12 season, 30 health care 
providers reported the total number of 
patients seen in their practices and the 
number of those patients seen for ILI by 
age group on a weekly basis.  
Outpatient ILI visits in Maine peaked in 
November (MMWR week 45) and again 
in April (MMWR weeks 12-16).  The 
New England region peaked in 
December and again in February.  
 
Hospital Inpatients 
Inpatient surveillance for respiratory 
illness admissions in Maine was 
conducted in collaboration with four 
hospitals.  During the 2011-12 season, 
four hospitals reported the number of 
patients admitted to the hospital and the 
number of those patients admitted for 
influenza  or pneumonia using admitting 
diagnoses.  Hospital admissions for 
influenza, pneumonia, or respiratory 
illness were highest in the first week of 
March (MMWR week 10). 
 
Emergency Room Visits 
Syndromic surveillance was conducted 
in the Emergency Departments of 24 
hospitals and analyzed using the Early 
Aberration Reporting System (EARS).  
These visits are grouped by chief 
complaint.  The percentage of ED visits 
that had a chief complaint consistent 
with ILI peaked in the end of February, 
beginning of March (MMWR week 9) 
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HETL 
M a i n e  C D C ’ s  H e a l t h  a n d 
Environmental Testing Laboratory 
(HETL) worked collaboratively with 
hospitals and private laboratories to 
collect specimens for respiratory virus 
testing and influenza positive isolate 
subtyping.  HETL reported the number 
of specimens received for respiratory 
virus testing and the number positive for 
influenza A(pH1N1), A(H3), A (unable 
to subtype), and influenza B by 
specimen collection date.  During the 
2011-12 season, 840 respiratory 
specimens were tested by HETL for 
influenza.  Of those 77 (9.2%) were 
positive for influenza (14 for influenza 
A/pH1N1, 40 for influenza A/H3,  2 for 
influenza A unable to subtype, and 21 
for influenza B). 
 
Reference Labs 
Two Maine reference laboratories, and 
many national reference laboratories 
submitted reports of laboratory-
confirmed influenza by culture or 
reverse-transcriptase polymerase chain 
reaction (RT-PCR).  During the 2011-
12 season,  115 specimens were positive 
for influenza (12 for influenza A/
pH1N1, 6 for influenza A/H3, 69 for 
influenza A without subtype, and 28 for 
influenza B). 
 
Rapid testing 
Many hospitals, labs, and physician 
offices voluntarily report positive rapid 
antigen tests to the state.  During the 
2011-12 season 48 positive tests were 
reported, 37 for influenza A, 7 for 
influenza B, and 4 for influenza, 
unsubtyped.   
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Hantavirus Pulmonary Syndrome – First Case in Maine, 2011 
Hantavirus pulmonary syndrome (HPS) is a life-threatening illness first identified in 1993 following an 
outbreak of unexplained, severe pulmonary illness in the southwestern United States. HPS is caused by 
hantavirus and is transmitted to humans by exposure to excreta of infected rodents.  In the Northeast the 
most common carrier of hantavirus is the white-footed mouse.   Humans contract the illness when they 
breathe aerosolized urine, droppings, or saliva of the infected rodent.  As of December 15, 2010, a total 
of 560 HPS cases from 32 states had been reported to CDC, but none were diagnosed, or had exposures, 
in Maine.  
 
On April 25, 2011, the Maine CDC was notified of a suspected case of HPS in a Maine resident aged 70 
years with no recent out-of-state travel. The patient presented to a community hospital in early April 
with a 5-day history of fatigue, decreased appetite, weakness, chills, muscle aches, and progressive 
shortness of breath.  After intensive care in a tertiary hospital the patient was discharged to a skilled 
nursing facility one month after presentation and recovered with extensive rehabilitation. 
 
An investigation revealed that the patient had potential exposure to rodent excreta in several areas of a 
farm. The patient reportedly had climbed a ladder to place rodenticide in the upper level of a shed, 
which was noted to have rodent droppings scattered on insulation.  No one else in the home or employed 
on the farm became ill. 
 
This case highlights the importance of provider and public awareness of HPS and risk factors for 
hantavirus infection, even in regions of the United States that have not previously had documented 
cases. Early recognition of HPS can reduce mortality. 
 
It is important to avoid exposure to hantavirus.  Prevention of HPS includes the following: 
Seal Up – seal up rodent entry holes or gaps in living areas 
Trap Up – trap rodents with an appropriate snap trap 
Clean Up – clean rodent food sources and nesting sites.   It is important to take appropriate 
precautions when cleaning rodent infested areas.  These steps include applying gloves and 
thoroughly wetting the affected area with a bleach solution before wiping up contamination with a 
damp cloth. 
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Community Outbreak of Shigellosis — Maine, 2011 
Shigellosis is an acute bacterial infection characterized by diarrhea, vomiting, nausea, and fever. 
Symptoms usually begin 24 to 48 hours after ingestion of the bacteria and typically last 5 to 7 days. 
Shigellosis is highly infectious; as few as 10 organisms can cause illness. Shigellosis can easily be 
passed from one person to another through the fecal-oral route. Shigella can be transmitted by eating 
contaminated food, contact with contaminated fomites, and drinking, swimming in or playing with 
contaminated water.  
 
Between 2006 and 2010 the median number of Shigella cases per year in Maine was 8. The 24 cases 
involved in this outbreak was higher than what is usually seen in the state in an entire year. 
 
In May 2011, Maine CDC received a report of a laboratory confirmed case of Shigella in an adult male 
from Androscoggin county. Additional testing at the Health and Environmental Testing Laboratory 
(HETL) confirmed the specimen as Shigella sonnei. A case investigation was conducted by Maine CDC 
to identify possible sources of exposure, search for additional cases and implement control measures to 
prevent further transmission. An interview with the patient revealed no ill contacts and no recent travel. 
Over the next six months, an additional 14 confirmed cases of shigellosis were reported in residents of 
Androscoggin county. There were nine probable cases identified in family and household contacts of 
confirmed cases. Of the 24 cases reported, 19 occurred in residents of an ethnic community in 
Androscoggin county. Twenty (83%) of the 24 cases were less than 18 years old. 
 
The investigation focused on finding similarities among exposures reported by infected persons. 
Exposures such as swimming at a local recreation site, shopping at local markets, and association with a 
particular housing complex, including an onsite child care center, were explored. As the outbreak 
continued, however, it became evident that there was ongoing person to person transmission or a 
recurring exposure. The focus shifted to promoting prevention messages in the community. Cases were 
linked by DNA “fingerprinting” through specific diagnostic testing, pulsed-field gel electrophoresis 
(PFGE). The source of infection could not be determined.  
 
The most important way to prevent the spread of Shigella is through routine and thorough hand washing, 
especially after using the toilet, changing a diaper, and before preparing food or beverages. Other 
prevention recommendations include: 
 
 Supervise children washing hands to ensure washing hands properly 
 Properly dispose of soiled diapers 
 Clean diaper changing areas with a disinfectant such as household bleach after use 
 Exclude individuals who work in daycare, healthcare with direct patient contact or food handlers 
from the work place 
 Exclude symptomatic children from daycare or other child group activity settings 
 People with diarrhea should not prepare or serve food or beverages for others 
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Outbreak of Salmonella Typhimurium - 2011 
On December 8, 2011 the federal CDC informed the Maine CDC of 3 cases of Salmonella 
Typhimurium that matched a national cluster centered in the northeastern states.  In the following week 
a fourth case was identified in Maine with a DNA fingerprint matching to a national cluster.  The 
common exposure reported by cases was consumption of ground beef purchased at a common 
supermarket chain.  
 
Interviews were conducted with each of the 4 individuals in Maine.  The initial interview identified 
ground beef as a common food consumed.  The second targeted questionnaire revealed types of ground 
beef and place of purchase.  Individuals were instructed to call Store A’s hotline to receive receipts of 
purchase if they no longer had them to verify the date and time of purchase.  The Maine cases resided 
in four different counties and were unrelated to each other.  Two of the individuals were hospitalized. 
All four recovered from their illness.  The Salmonella strain that was identified as Typhimurium was 
found to be resistant to several commonly used antibiotics.    A sample of ground beef from the freezer 
of one of the Maine cases was analyzed and found to match the genetic strain of the outbreak.  Table 1 
compares the characteristics of the Maine cases to those in other states. 
 
The investigation resulted in a large ground beef recall by Store A.  A full investigation was performed 
by the USDA to determine where the ground beef might have originated.   Due to common Store A 
practices in mixing and grinding ground beef from multiple sources, considered legal by the USDA, no 
further trace back could be performed.  This outbreak highlighted limitations in conducting trace backs. 
Congress and regulatory agencies are considering evaluating grinding practices to ensure that a 
comprehensive trace back will reveal the source of the contamination. 
Appendix D 
Table 1. Characteristics of Salmonella Typhimurium cases, Maine and U.S. 
 Maine  US  
Cases  4 19 
Gender— male/female 2/2 10/9 
Age  31-79 yrs., median 46 yrs.  1-79 yrs., median 44 yrs.  
Counties/States  York (1), Cumberland (1), 
Waldo (1), Androscoggin
(1)  
HI(1), KY(1), MA(1), ME
(4),NH(6), NY(5), VT(1)  
Common Exposure  Ground beef (4): Store A 
(3), other store (1)  
Ground beef (14): Store A 
(12), other store (2)  
Hospitalizations  2 9 
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Influenza A/H3N2v—Maine, 2011 
Influenza viruses are known to circulate in non-human animals, including birds and swine.  Swine flu 
viruses do not normally infect humans, however sporadic human infections do occur.  Most commonly, 
human infections with variant swine viruses occur in persons with exposure to infected pigs.  From 
August 2011 through December 2011, 12 humans in the U.S. became infected with influenza A swine 
flu viruses, also known as H3N2v.  Two of these infections occurred in children in Maine. 
 
On October 14, 2011 Maine’s Health and Environmental Testing Laboratory (HETL) notified the 
Division of Infectious Disease (DID) of an influenza A sample that was positive for H3 and the swine 
component of H1N1.  This sample was forwarded to federal CDC where it was confirmed as swine-
origin triple reassortant influenza A/H3N2.  The patient was a 7 year old male with onset of fever, 
cough, headache, sore throat and myalgia on October 7, 2011.  The patient had a history of asthma and 
had received the 2010-2011 influenza vaccine.  The patient visited an agricultural fair on multiple days 
and spent time in the swine barn.  The patient was treated with oseltamivir and recovered. 
 
On October 28, 2011 HETL notified DID of an influenza A sample that was weakly positive for H3, 
with swine exposure noted on the submission form.  The sample was forwarded to federal CDC where it 
was confirmed as swine-origin triple reassortant influenza A/H3N2.  The patient was an 8 year old male 
with  onset of fever, myalgia, and runny nose on October 22, 2011.  The patient visited the same 
agriculture fair over multiple days and participated in a pig scramble.  The patient also helped take care 
of pigs at family friend’s farm.  The patient had received the 2010-2011 influenza vaccine, was not 
treated with antivirals, and recovered. 
 
Both cases were interviewed and enhanced surveillance was recommended among their families and at 
their schools.  Although other cases of illness were reported, no other persons tested positive for 
influenza.  Maine CDC was not able to identify any human to human transmission from either case. 
 
The agricultural response included contacting all the swine exhibitors from the agricultural fair.  All 
farms were visited by a veterinarian, and any ill pigs were swabbed for influenza.  No swine tested 
positive, however there was a time lapse between the fair and testing.  The residents and employees of 
the farms were interviewed about influenza like illness symptoms. Although ill individuals were 
identified, no other persons tested positive for influenza. 
 
There are many ways to reduce the risk of influenza, including H3N2v influenza: 
  Wash your hands, including after contact with pigs or other animals  
  Cover your cough to help protect other humans AND pigs 
  Stay home if you are ill, and do not come into contact with pigs if you are ill.  They can get the 
virus from you, and pass it along to another pig, or another person 
  Get vaccinated.  The vaccine will not prevent infection with new, variant viruses, but it can help 
reduce the severity of illness, and will help protect both humans and animals from the commonly 
circulating strains of influenza. 
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Clostridium difficile Outbreaks – Maine, 2011 
Clostridium difficile (C. difficile) is a spore-forming, Gram-positive anaerobic bacillus that produces two 
exotoxins: toxin A and toxin B. It is transmitted through the fecal-oral route and direct contact with 
contaminated surfaces. More than 90% of healthcare associated C. difficile infection occur after or 
during antibiotic therapy. Patients are at greater risk for C. difficile infection when they are older, take 
antibiotics, proton pump inhibitors or H2 blockers, have gastrointestinal surgery, have underlying 
conditions including immune system suppression, and stay in healthcare settings for long periods of 
time.  
 
Among patients who are hospitalized for 1-2 weeks, 13% develop C. difficile illness; for patients 
hospitalized for more than 4 weeks, up to 50% may develop C. difficile illness.  A person can be 
colonized with C. difficile; that is, the patient has no clinical symptoms but tests positive for C. difficile 
and/or its toxin. One study estimated 15% of healthcare workers are colonized with C. difficile, although 
other studies have shown lower rates.   C. difficile infection is diagnosed with a positive test for C. 
difficile and/or its toxin and clinical symptoms. The national rate of C. difficile infections acquired in 
hospitals is 2.8 per 10,000 patient days, but this is considered an underestimate as it does not include 
cases diagnosed after patients leave the hospital.   
 
Maine CDC supported the development of a new laboratory test to be used in outbreaks.  Pulsed field 
gel electrophoresis (PFGE) for C. difficile testing is now available at the Maine Health and 
Environmental Testing Laboratory (HETL) for outbreak investigations.  In 2011, four outbreaks of C. 
difficile were reported to Maine CDC; three in nursing facilities and one in a hospital setting. 
 
 One nursing facility in central Maine reported 7 laboratory confirmed and one probable case 
among residents over a 12 month period. Among specimens collected from 12 residents, 6 were 
positive by PCR and 4 had PFGE testing completed. Three of the specimens matched by PFGE, 
and all three were epi-linked, either through eating meals together or were roommates at the 
facility. Two of the cases were roommates, however, illness onset was ten months later. 
 A second central Maine nursing home reported 8 confirmed cases and 1 probable case. None of 
the cases matched by PFGE, thus no evidence of cross contamination was found.  
 A nursing home in Western Maine had 2 cases with a possible epidemiological linkage. The two 
cases were found to have matching PFGE patterns.  Enhanced environmental cleaning was 
performed and no new cases have occurred as of May 2012. 
 In a hospital outbreak, C. difficile spread throughout floor A of the facility over  three months. 
After a patient from floor A was transferred to floor B, the outbreak spread and patients in six 
rooms on the first floor were diagnosed with C. difficile  in less than five weeks. Nine laboratory 
confirmed cases were identified in patients in ten different rooms on two floors. A total of four 
specimens from both floor A and B were found to be a related strain by PFGE testing.  
 
In all the outbreaks investigated, all related C. difficile strains were the NAP1 variety. This variety is 
associated with increased incidence and severity of disease.  Of note, PFGE testing has demonstrated 28 
patterns throughout Maine. Aroostook county, southern Maine, central Maine, and Bangor have been 
found to have unique C. difficile patterns. 
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Healthcare Associated Infections 
Healthcare Associated Infections (HAIs) are among the top ten causes of death in the U.S. It is estimated 
that 1.7 million HAIs occur per year in the U.S., and result in 99,000 deaths, at a cost of $33 billion.  
Because HAIs have a substantial impact on health and heathcare costs, there is a growing focus on the 
need to monitor and prevent HAIs.  In 2009, the Maine CDC received federal funds to develop an HAI 
prevention program.  The Maine CDC works closely with an advisory group which has representatives 
from all Maine hospitals. Additionally, Maine CDC coordinates with other state and federal agencies, 
healthcare providers, and professional groups to prevent HAIs.  The focus of the program is for hospitals 
to report HAIs using uniform nationally recognized definitions.  In particular, the focus is to reduce: 
1. Central line associated bloodstream infections (CLABSI) 
2. Methicillin resistant Staphylococcus aureus (MRSA) infections 
3. Clostridium difficile infections,  
4. Catheter associated urinary tract infections, and 
5. Surgical site infections. 
 
Accomplishments of the HAI program to date: 
 Creation of a new infrastructure within Maine CDC for the HAI program. 
 Working closely with the Maine Health Data Organization and the Maine Quality Forum to 
streamline HAI reporting by hospitals. 
 Providing data management support and epidemiology training for Infection Preventionists.  
 Educating and supporting efforts for hospitals to develop antibiotic stewardship programs. 
 Providing training on hospital outbreak investigations and improving healthcare facility 
outbreak reporting to Maine CDC. 
 Creating an HAI website for the general public. 
 Increasing state public health lab capacity to identify organisms likely to cause HAI outbreaks. 
 
HAI program future projects include: 
 Analysis and validation of MRSA-HAI, Clostridium difficile-HAI, and central line infections. 
 Continue to supply assistance for outbreaks occurring in hospitals and Long Term Care 
Facilities. 
 Provide training and resource materials for infection prevention to Long Term Care Facilities 
throughout the state. 
 Educate hospitals and physicians regarding antibiotic stewardship in an effort to reduce 
multiple drug resistant organisms. 
 
HAI reduction in Maine 
Through the efforts of multiple state agencies and professional organizations, Maine has reduced central 
line associated bloodstream infections by 44%, from July 1, 2007– June 30, 2008 to July 1, 2010 – June 
30, 2011.  The use of  “bundles” to prevent central line infections improved from 78% to 96% for 
surgical areas and 71% to 92% in intensive care units during that same time period. Now that hospitals 
are reporting standardized data in the National Healthcare Safety Network (NHSN), Maine CDC will be 
able to analyze the data for reductions in MRSA-HAIs and C. difficile-HAIs over time. 
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2011 Tick Data Collected by the Maine Medical Center Research Institute 
Vector-Borne Disease Laboratory 
 
The Maine Medical Center Research Institute (MMCRI) Vector-Borne Disease 
Laboratory operates a free tick identification service as part of a program to establish the 
distribution of deer ticks (Ixodes scapularis) in the state. Ticks found on people and pets 
are submitted with information on where the tick(s) may have been acquired. Ticks are 
not tested for the presence of Lyme bacteria and MMCRI only accepts ticks from the 
state of Maine. 
 
It is important to note that this passive sampling could be influenced by a variety of 
extraneous factors (e.g. proximity to the laboratory, level of citizen concern about Lyme 
disease in an area, or whether or not a particular area is already widely known to have a 
deer tick presence). 
 
Number of Ticks Identified by County and Type, Maine, 2011 
 County 
Ixodes 
scapularis 
(Deer 
Tick) 
Dermacentor 
variabilis 
(American 
Dog Tick) 
Ixodes 
cookei 
(Woodchuck 
Tick) 
A. 
americanum 
(Lonestar 
Tick) 
Androscoggin 33 3 0 1 
Aroostook 12 1 2 1 
Cumberland 219 36 2 0 
Franklin 17 3 2 0 
Hancock 183 16 2 2 
Kennebec 56 8 1 1 
Knox 51 13 0 0 
Lincoln 21 2 0 0 
Oxford 44 2 3 0 
Penobscot 120 9 4 1 
Piscataquis 23 1 2 0 
Sagadahoc 27 5 0 0 
Somerset 39 7 3 0 
Waldo 82 4 3 0 
Washington 14 0 0 0 
York 74 21 0 0 
Unspecified 17 1 1 0 
Totals 1032 132 25 6 
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Why is it important to submit ticks for identification? 
It is important for a physician (or a pet's veterinarian) to know what species of tick was 
involved in a bite.  It is also important for surveillance purposes to know the type of tick 
and where ticks are found. 
 
How are ticks submitted? 
Remove ticks by grasping them with fine tweezers as near to the skin as possible and 
pull up gently but firmly.  A tick spoon is also effective. The barbed mouth parts may not 
let go easily.  It may take several minutes or more.  Do not handle ticks with bare hands.  
Ticks should be sealed in a small, crushproof vial of 70% alcohol.  The vial should be 
padded with absorbent paper towel and sealed in a plastic bag, and mailed along with a 
completed submission form to:  
Vector-borne Disease Laboratory 
Maine Medical Center Research Institute 
75 John Roberts Rd., Suite 9B  
South Portland, ME 04106  
Print out the submission form from http://www.mmcri.org/lyme/lymeform.html, complete 
it, and mail it in with the specimen.  A report of the tick's identification will be sent to the 
submitter as soon as possible, usually within five days. A map may also be sent to assist 
in the identification of the site where tick exposure occurred. The public may address 
questions to the laboratory’s email address: ticklab@mmc.org. 
 
 
Map Caption 
A map summarizing the number of Ixodes scapularis (deer tick) submitted per Minor 
Civil Division, 1989 through 2011. 
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  NOTIFIABLE CONDITIONS LIST   
  Maine Department of Health and Human Services  
    Center for Disease Control and Prevention 
  
           Conditions in BOLD must be reported immediately   All others must be reported in 48 hours 
 
 
Reportable Disease or Condition Laboratory Specimen Submission 
Acquired Immunodeficiency Syndrome (AIDS) 
Anthrax   
Arboviral Infection  
Babesiosis 
Botulism  
Brucellosis  
Campylobacteriosis 
Carbon Monoxide Poisoning, including 
- Clinical signs, symptoms or known 
exposure consistent with diagnosis of  
        carbon monoxide poisoning and/or: 
        a carboxyhemoglobin (COHb) level  
        >5% 
Chancroid 
Chlamydia 
Chickenpox (Varicella) 
Creutzfeldt-Jakob disease, <55 years of age 
Cryptosporidiosis 
Dengue 
Diphtheria  
E. coli, Shiga toxin-producing (STEC) disease  
   including E. coli: 0157:H7                                                                                                                                                                        
Ehrlichiosis 
Giardiasis 
Gonorrhea 
Haemophilus influenzae disease, invasive,    
   include all serotypes           
Hantavirus, pulmonary syndrome 
Hemolytic-uremic syndrome (post-diarrheal) 
Hepatitis A, B, C, D, E (acute) 
Hepatitis B (chronic, and/or perinatal) 
Hepatitis C (chronic) 
Hepatitis, acute (etiologic tests pending or  
  etiology unknown) 
Human Immunodeficiency Virus (HIV), 
   including: 
- Confirmed, positive antibody tests 
- Viral load tests, all results  
- CD4 lymphocyte counts, all results  
Influenza-associated pediatric death  
Influenza-like illness outbreaks 
Influenza A, Novel 
Legionellosis 
Leptospirosis 
Listeriosis  
Lyme Disease  
Malaria 
Measles   
Meningitis (bacterial) 
Meningococcal Invasive Disease  
Mumps  
Paralytic Shellfish Poisoning 
Pertussis  
Plague 
Poliomyelitis 
Psittacosis 
Q Fever  
Rabies (human and animal)  
Rabies Post-Exposure Prophylaxis 
Ricin Poisoning  
Rocky Mountain Spotted Fever 
Rubella (including congenital)  
Salmonellosis  
Severe Acute Respiratory Syndrome  
  (SARS) 
Shigellosis  
Smallpox  
Staphylococcus aureus, Methicillin-
  Resistant (MRSA) invasive,  
Staphylococcus aureus with     
  resistance (VRSA) or intermediate   
  resistance (VISA) to Vancomycin     
  isolated from any site 
Staphylococcal enterotoxin B  
Streptococcal invasive disease, Group A 
Streptococcal invasive disease, Group B 
Streptococcus pneumoniae, invasive          
  disease                                                         
Syphilis 
Tetanus  
Toxoplasmosis 
Trichinosis  
Tuberculosis (active and presumptive  
  cases)    
Tularemia  
Unusual or increased case incidence,  
  critical illness, unexplained death(s) 
  of any suspect infectious disease 
Vibrio species, including Cholera  
Viral Hemorrhagic Fever 
Venezuelan equine encephalitis 
Yellow Fever 
Yersiniosis 
Directors of laboratories are to submit cultures or clinical 
specimens for the following to the Maine Health and 
Environmental Testing Laboratory for confirmation, typing 
and/or antibiotic sensitivity:   
 
Acid-Fast Bacillus 
Bacillus anthracis 
Bordetella pertussis 
Brucella species 
Clostridium tetani 
Clostridium botulinum 
Corynebacterium diphtheriae 
Coxiella burnetii 
Escherichia coli, Shiga toxin-producing 
Haemophilus influenzae 
Human Immunodeficiency Virus 
Influenza virus, Novel 
Listeria monocytogenes 
Mumps virus 
Mycobacterium tuberculosis 
Neisseria meningitidis 
Rabies virus
Ricin Poisoning 
Rubella virus 
Rubeola virus 
Salmonella species 
SARS Coronavirus 
Shigella species 
Toxoplasma gondii 
Variola virus 
Vibrio species 
Yersinia pestis 
 
 
 
 
 
 
 
 
 
Who must report: Health Care Providers, Medical Laboratories, Health Care Facilities, 
Administrators, Health Officers, Veterinarians 
When to report: 
 Conditions in BOLD are reportable immediately by telephone on recognition or strong 
suspicion of disease 
 All others are reportable by telephone, fax, or mail within 48 hours of recognition or 
strong suspicion of disease 
What to report: 
Disease reports must include as much of the following as is known: 
 Disease or condition diagnosed or suspected 
 Patient’s name, date of birth, address, phone number, occupation and race 
 Diagnostic laboratory findings and dates of test relevant to the notifiable condition 
 Health care provider name, address and phone number 
 Name and phone number of person making the report 
 
Complete Rules for the Control of Notifiable Conditions at: 
http://www.maine.gov/dhhs/boh/ddc/epi/disease-reporting/index.shtml  
 
 
 
 April 4, 2008 
Disease Reporting 
24 Hours A Day 
7 Days A Week  
 
Telephone 
1-800-821-5821 
 
Fax 
1-800-293-7534 
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The Department of Health and Human Services (DHHS) does not discriminate on the 
basis of disability, race, color, creed, gender, age, sexual orientation, or national origin, in 
admission to, access to or operation of its programs, services, activities, or its hiring or 
employment practices.  This notice is provided as required by Title II of the Americans 
with Disabilities Act of 1990 and in accordance with the Civil Rights Acts of 1964 as 
amended.  Section 504 of the Rehabilitation Act of 1973 as amended, the Age 
Discrimination Act of 1975, Title IX of the Education Amendments of 1972 and the 
Maine Human Rights Act.  Questions, concerns, complaints, or requests for additional 
information regarding civil rights may be forwarded to the DHHS’ ADA 
Compliance/EEO Coordinator, State House Station #11, Augusta, Maine 04333, 207-
287-4289 (V) or 207-287-3488 (V), TTY: 800-606-0215.  Individuals who need auxiliary 
aids for effective communication in programs and services of DHHS are invited to make 
their needs and preferences known to the ADA Compliance/EEO Coordinator.  This 
notice is available in alternate formats, upon request. 
 
 
 
 
